<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//www.izb-online.de/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:xhtml="http://www.w3.org/1999/xhtml">
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/</loc>
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/" />
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/" />
		<lastmod>2026-09-30T11:54:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/</loc>
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/" />
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/" />
		<lastmod>2026-09-30T11:54:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/23-students-from-europe-visited-the-izb-as-part-of-the-amgen-scholar-program/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/23-studenten-aus-europa-besuchten-im-rahmen-des-amgen-scholar-program-das-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/23-students-from-europe-visited-the-izb-as-part-of-the-amgen-scholar-program/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/23-studenten-aus-europa-besuchten-im-rahmen-des-amgen-scholar-program-das-izb/" />
		<lastmod>2024-12-18T09:37:57+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/DZ6_0307-2000x1098-1.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/catalym-staerkt-board-of-directors-und-wissenschaftlichen-beirat-mit-renommierten-branchenexperten-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/catalym-staerkt-board-of-directors-und-wissenschaftlichen-beirat-mit-renommierten-branchenexperten-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/catalym-staerkt-board-of-directors-und-wissenschaftlichen-beirat-mit-renommierten-branchenexperten-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-09T10:07:15+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/SCI_Illustrate_5th_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/tubulis-praesentiert-neue-praeklinische-daten-fuer-die-fuehrenden-adc-kandidaten-gegen-solide-tumore-auf-der-aacr-jahrestagung-2024-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/tubulis-praesentiert-neue-praeklinische-daten-fuer-die-fuehrenden-adc-kandidaten-gegen-solide-tumore-auf-der-aacr-jahrestagung-2024-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/tubulis-presents-novel-preclinical-data-for-lead-adc-candidates-targeting-solid-tumors-at-aacr-2024-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/tubulis-praesentiert-neue-praeklinische-daten-fuer-die-fuehrenden-adc-kandidaten-gegen-solide-tumore-auf-der-aacr-jahrestagung-2024-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-09T10:07:15+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Krebszellen_Tubulis_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/leon-nanodrugs-verstaerkt-fuehrungsteam-mit-neuem-ceo/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/leon-nanodrugs-verstaerkt-fuehrungsteam-mit-neuem-ceo/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/leon-nanodrugs-strengthens-leadership-team-with-new-ceo/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/leon-nanodrugs-verstaerkt-fuehrungsteam-mit-neuem-ceo/" />
		<lastmod>2026-07-09T10:07:15+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Dr.-Wolfgang-Hofmann-CEO-of-LEON_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/catalym-staerkt-board-of-directors-und-wissenschaftlichen-beirat-mit-renommierten-branchenexperten-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/catalym-strengthens-board-of-directors-and-scientific-advisory-board-with-key-appointments-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/catalym-staerkt-board-of-directors-und-wissenschaftlichen-beirat-mit-renommierten-branchenexperten-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-09T10:08:25+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/SCI_Illustrate_5th_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/tubulis-presents-novel-preclinical-data-for-lead-adc-candidates-targeting-solid-tumors-at-aacr-2024-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/tubulis-praesentiert-neue-praeklinische-daten-fuer-die-fuehrenden-adc-kandidaten-gegen-solide-tumore-auf-der-aacr-jahrestagung-2024-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/tubulis-presents-novel-preclinical-data-for-lead-adc-candidates-targeting-solid-tumors-at-aacr-2024-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/tubulis-praesentiert-neue-praeklinische-daten-fuer-die-fuehrenden-adc-kandidaten-gegen-solide-tumore-auf-der-aacr-jahrestagung-2024-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-09T10:08:25+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Krebszellen_Tubulis_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/leon-nanodrugs-strengthens-leadership-team-with-new-ceo/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/leon-nanodrugs-verstaerkt-fuehrungsteam-mit-neuem-ceo/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/leon-nanodrugs-strengthens-leadership-team-with-new-ceo/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/leon-nanodrugs-verstaerkt-fuehrungsteam-mit-neuem-ceo/" />
		<lastmod>2026-07-09T10:08:26+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Dr.-Wolfgang-Hofmann-CEO-of-LEON_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/eisbach-fda-genehmigt-ind-antrag-fuer-fuehrenden-medikamentenkandidaten-eis-12656-einen-erstklassigen-allosterische-inhibitor-von-alc1-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/eisbach-fda-genehmigt-ind-antrag-fuer-fuehrenden-medikamentenkandidaten-eis-12656-einen-erstklassigen-allosterische-inhibitor-von-alc1-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/eisbach-receives-ind-clearance-for-lead-candidate-eis-12656-a-first-in-class-allosteric-inhibitor-of-alc1-from-the-fda-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/eisbach-fda-genehmigt-ind-antrag-fuer-fuehrenden-medikamentenkandidaten-eis-12656-einen-erstklassigen-allosterische-inhibitor-von-alc1-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T11:21:11+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Eisbach-Bio_iStock-KamiPhotos_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/insempra-schliesst-20-millionen-us-dollar-finanzierung-ab-um-die-entwicklung-von-natuerlichen-inhaltsstoffen-der-naechsten-generation-voranzutreiben-innovations-und-gruenderzentrum-biotechnologie/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/insempra-schliesst-20-millionen-us-dollar-finanzierung-ab-um-die-entwicklung-von-natuerlichen-inhaltsstoffen-der-naechsten-generation-voranzutreiben-innovations-und-gruenderzentrum-biotechnologie/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/insempra-completes-20-million-financing-to-advance-the-development-of-next-generation-bio-based-ingredients-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/insempra-schliesst-20-millionen-us-dollar-finanzierung-ab-um-die-entwicklung-von-natuerlichen-inhaltsstoffen-der-naechsten-generation-voranzutreiben-innovations-und-gruenderzentrum-biotechnologie/" />
		<lastmod>2026-07-15T11:21:12+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Insempra_Produkte_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/thermosome-erreicht-naechste-dosisstufe-in-phase-i-studie-mit-wirkstoffkandidaten-the001-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/thermosome-erreicht-naechste-dosisstufe-in-phase-i-studie-mit-wirkstoffkandidaten-the001-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/thermosome-advances-phase-i-trial-with-lead-candidate-to-next-dose-level-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/thermosome-erreicht-naechste-dosisstufe-in-phase-i-studie-mit-wirkstoffkandidaten-the001-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T11:21:14+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Dr.-Frank-Hermann-CMO-Thermosome_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/tubulis-lizenziert-ind-fertiges-adc-fuer-die-behandlung-von-lymphomen-an-oncoteq-aus-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/tubulis-lizenziert-ind-fertiges-adc-fuer-die-behandlung-von-lymphomen-an-oncoteq-aus-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/tubulis-out-licenses-ind-ready-adc-for-the-treatment-of-lymphoma-to-oncoteq-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/tubulis-lizenziert-ind-fertiges-adc-fuer-die-behandlung-von-lymphomen-an-oncoteq-aus-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T11:21:15+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Tubulis_Behandlung-einer-Lymphompatientin_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/eisbach-receives-ind-clearance-for-lead-candidate-eis-12656-a-first-in-class-allosteric-inhibitor-of-alc1-from-the-fda-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/eisbach-fda-genehmigt-ind-antrag-fuer-fuehrenden-medikamentenkandidaten-eis-12656-einen-erstklassigen-allosterische-inhibitor-von-alc1-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/eisbach-receives-ind-clearance-for-lead-candidate-eis-12656-a-first-in-class-allosteric-inhibitor-of-alc1-from-the-fda-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/eisbach-fda-genehmigt-ind-antrag-fuer-fuehrenden-medikamentenkandidaten-eis-12656-einen-erstklassigen-allosterische-inhibitor-von-alc1-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T11:21:24+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Eisbach-Bio_iStock-KamiPhotos_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/insempra-completes-20-million-financing-to-advance-the-development-of-next-generation-bio-based-ingredients-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/insempra-schliesst-20-millionen-us-dollar-finanzierung-ab-um-die-entwicklung-von-natuerlichen-inhaltsstoffen-der-naechsten-generation-voranzutreiben-innovations-und-gruenderzentrum-biotechnologie/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/insempra-completes-20-million-financing-to-advance-the-development-of-next-generation-bio-based-ingredients-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/insempra-schliesst-20-millionen-us-dollar-finanzierung-ab-um-die-entwicklung-von-natuerlichen-inhaltsstoffen-der-naechsten-generation-voranzutreiben-innovations-und-gruenderzentrum-biotechnologie/" />
		<lastmod>2026-07-15T11:21:27+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Insempra_Produkte_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/thermosome-advances-phase-i-trial-with-lead-candidate-to-next-dose-level-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/thermosome-erreicht-naechste-dosisstufe-in-phase-i-studie-mit-wirkstoffkandidaten-the001-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/thermosome-advances-phase-i-trial-with-lead-candidate-to-next-dose-level-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/thermosome-erreicht-naechste-dosisstufe-in-phase-i-studie-mit-wirkstoffkandidaten-the001-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T11:21:29+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Dr.-Frank-Hermann-CMO-Thermosome_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/tubulis-out-licenses-ind-ready-adc-for-the-treatment-of-lymphoma-to-oncoteq-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/tubulis-lizenziert-ind-fertiges-adc-fuer-die-behandlung-von-lymphomen-an-oncoteq-aus-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/tubulis-out-licenses-ind-ready-adc-for-the-treatment-of-lymphoma-to-oncoteq-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/tubulis-lizenziert-ind-fertiges-adc-fuer-die-behandlung-von-lymphomen-an-oncoteq-aus-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T11:21:37+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Tubulis_Behandlung-einer-Lymphompatientin_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/netzwerktreffen-mit-den-partnern-der-plattform-life-sciences-im-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/netzwerktreffen-mit-den-partnern-der-plattform-life-sciences-im-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/netzwerktreffen-mit-den-partnern-der-plattform-life-sciences-im-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/netzwerktreffen-mit-den-partnern-der-plattform-life-sciences-im-izb/" />
		<lastmod>2026-07-15T11:23:11+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Netzwerktreffen-mit-den-Partnern-der-Plattform-Life-Sciences-im-IZB.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/weihnachtsgruesse-aus-dem-izb-2022/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/weihnachtsgruesse-aus-dem-izb-2022/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/weihnachtsgruesse-aus-dem-izb-2022/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/weihnachtsgruesse-aus-dem-izb-2022/" />
		<lastmod>2026-07-15T11:23:11+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/IZB_Weichnachtsakrte.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/morphosys-schliesst-exklusive-globale-lizenzvereinbarung-mit-novartis-fuer-praeklinisches-onkologie-programm-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/morphosys-schliesst-exklusive-globale-lizenzvereinbarung-mit-novartis-fuer-praeklinisches-onkologie-programm-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/morphosys-signs-exclusive-global-license-agreement-with-novartis-for-preclinical-oncology-program-innovations-und-grunderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/morphosys-schliesst-exklusive-globale-lizenzvereinbarung-mit-novartis-fuer-praeklinisches-onkologie-programm-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T11:23:12+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/MorphoSys-Onkologie-Pogramm.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/izb-biotech-news-neuer-hightech-ansatz-zur-fruehzeitigen-erkennung-kranker-zellen-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/izb-biotech-news-neuer-hightech-ansatz-zur-fruehzeitigen-erkennung-kranker-zellen-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/new-high-tech-approach-to-detect-diseased-cells-at-an-early-stage-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/izb-biotech-news-neuer-hightech-ansatz-zur-fruehzeitigen-erkennung-kranker-zellen-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T11:23:13+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Helmholtz-Zentrum_neuer-Ansatz_Bild1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/leibniz-institut-in-freising-identifiziert-neue-biomarker-fuer-den-kaffeekonsum-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/leibniz-institut-in-freising-identifiziert-neue-biomarker-fuer-den-kaffeekonsum-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/leibniz-institute-in-freising-identifies-new-biomarkers-for-coffee-consumption-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/leibniz-institut-in-freising-identifiziert-neue-biomarker-fuer-den-kaffeekonsum-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T11:23:13+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/biomarker-kaffeekonsum.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/ein-einzigartiger-ansatz-fuer-die-biopharmazeutische-formulierungsentwicklung/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/ein-einzigartiger-ansatz-fuer-die-biopharmazeutische-formulierungsentwicklung/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/a-unique-approach-to-biopharmaceutical-formulation-development/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/ein-einzigartiger-ansatz-fuer-die-biopharmazeutische-formulierungsentwicklung/" />
		<lastmod>2026-07-15T11:23:14+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/adivo-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/vivoryon-therapeutics-gibt-update-zur-klinischen-entwicklung-seines-lead-kandidaten-gegen-alzheimer/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/vivoryon-therapeutics-gibt-update-zur-klinischen-entwicklung-seines-lead-kandidaten-gegen-alzheimer/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/vivoryon-therapeutics-gives-update-on-clinical-development-of-its-lead-candidate-against-alzheimers-disease/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/vivoryon-therapeutics-gibt-update-zur-klinischen-entwicklung-seines-lead-kandidaten-gegen-alzheimer/" />
		<lastmod>2026-07-15T11:23:18+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Vivoryon-2023-03_thumb.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/erc-advanced-grant-in-hoehe-von-knapp-21-mio-euro-fuer-max-planck-direktorin-prof-dr-brenda-schulman-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/erc-advanced-grant-in-hoehe-von-knapp-21-mio-euro-fuer-max-planck-direktorin-prof-dr-brenda-schulman-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/erc-advanced-grant-of-nearly-2-1-million-euros-for-max-planck-director-professor-dr-brenda-schulman-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/erc-advanced-grant-in-hoehe-von-knapp-21-mio-euro-fuer-max-planck-direktorin-prof-dr-brenda-schulman-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T11:23:19+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/brenda-schulman_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/adivo-wird-teil-des-weltweit-fuehrenden-unternehmens-fuer-tiergesundheit-zoetis-alumnus-des-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/adivo-wird-teil-des-weltweit-fuehrenden-unternehmens-fuer-tiergesundheit-zoetis-alumnus-des-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/adivo-becomes-part-of-the-worlds-leading-animal-health-company-zoetis-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/adivo-wird-teil-des-weltweit-fuehrenden-unternehmens-fuer-tiergesundheit-zoetis-alumnus-des-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T11:23:20+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/a-management_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/morphosys-wirkstoff-tulmimetostat-erhaelt-fast-track-status-der-fda-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/morphosys-wirkstoff-tulmimetostat-erhaelt-fast-track-status-der-fda-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/morphosys-program-tulmimetostat-receives-fda-fast-track-designation-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/morphosys-wirkstoff-tulmimetostat-erhaelt-fast-track-status-der-fda-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T11:23:21+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Labor-MorphoSys_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/4sc-erhaelt-von-der-ema-den-orphan-drug-designation-fuer-resminostat-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/4sc-erhaelt-von-der-ema-den-orphan-drug-designation-fuer-resminostat-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/4scs-resminostat-receives-orphan-drug-designation-from-the-european-medicines-agency-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/4sc-erhaelt-von-der-ema-den-orphan-drug-designation-fuer-resminostat-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T11:23:22+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/4SC_cancer-treatment_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/ein-abend-fuer-neue-netzwerke-wirtschaftsempfang-2025-im-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/ein-abend-fuer-neue-netzwerke-wirtschaftsempfang-2025-im-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/an-evening-for-new-connections-business-reception-at-the-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/ein-abend-fuer-neue-netzwerke-wirtschaftsempfang-2025-im-izb/" />
		<lastmod>2026-07-15T11:24:02+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Wirtschaftsempfang-3.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/prof-corinna-dawid-leitet-das-leibniz-lsbtum/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/prof-corinna-dawid-leitet-das-leibniz-lsbtum/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/prof-corinna-dawid-leads-leibniz-lsbtum-into-the-future/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/prof-corinna-dawid-leitet-das-leibniz-lsbtum/" />
		<lastmod>2026-07-15T11:24:02+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Prof.-Dr.-Corinna-Dawid_Leibniz-Institut_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/netzwerktreffen-mit-den-partnern-der-plattform-life-sciences-im-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/netzwerktreffen-mit-den-partnern-der-plattform-life-sciences-im-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/netzwerktreffen-mit-den-partnern-der-plattform-life-sciences-im-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/netzwerktreffen-mit-den-partnern-der-plattform-life-sciences-im-izb/" />
		<lastmod>2026-07-15T11:24:25+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Netzwerktreffen-mit-den-Partnern-der-Plattform-Life-Sciences-im-IZB.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/weihnachtsgruesse-aus-dem-izb-2022/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/weihnachtsgruesse-aus-dem-izb-2022/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/weihnachtsgruesse-aus-dem-izb-2022/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/weihnachtsgruesse-aus-dem-izb-2022/" />
		<lastmod>2026-07-15T11:24:25+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/IZB_Weichnachtsakrte.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/a-unique-approach-to-biopharmaceutical-formulation-development/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/ein-einzigartiger-ansatz-fuer-die-biopharmazeutische-formulierungsentwicklung/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/a-unique-approach-to-biopharmaceutical-formulation-development/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/ein-einzigartiger-ansatz-fuer-die-biopharmazeutische-formulierungsentwicklung/" />
		<lastmod>2026-07-15T11:24:26+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/vorlage_post-VIDEOSTORY.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/leibniz-institute-in-freising-identifies-new-biomarkers-for-coffee-consumption-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/leibniz-institut-in-freising-identifiziert-neue-biomarker-fuer-den-kaffeekonsum-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/leibniz-institute-in-freising-identifies-new-biomarkers-for-coffee-consumption-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/leibniz-institut-in-freising-identifiziert-neue-biomarker-fuer-den-kaffeekonsum-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T11:24:26+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/biomarker-kaffeekonsum.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/morphosys-signs-exclusive-global-license-agreement-with-novartis-for-preclinical-oncology-program-innovations-und-grunderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/morphosys-schliesst-exklusive-globale-lizenzvereinbarung-mit-novartis-fuer-praeklinisches-onkologie-programm-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/morphosys-signs-exclusive-global-license-agreement-with-novartis-for-preclinical-oncology-program-innovations-und-grunderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/morphosys-schliesst-exklusive-globale-lizenzvereinbarung-mit-novartis-fuer-praeklinisches-onkologie-programm-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T11:24:26+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/MorphoSys-Onkologie-Pogramm.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/amsilk-extends-series-c-financing-to-eur-54-million-backed-by-renowned-investors-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/amsilk-erweitert-serie-c-finanzierung-auf-54-mio-euro-unterstuetzt-von-namhaften-investoren-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/amsilk-extends-series-c-financing-to-eur-54-million-backed-by-renowned-investors-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/amsilk-erweitert-serie-c-finanzierung-auf-54-mio-euro-unterstuetzt-von-namhaften-investoren-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T11:24:27+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/AMSilk_Produktion_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/adivo-becomes-part-of-the-worlds-leading-animal-health-company-zoetis-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/adivo-wird-teil-des-weltweit-fuehrenden-unternehmens-fuer-tiergesundheit-zoetis-alumnus-des-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/adivo-becomes-part-of-the-worlds-leading-animal-health-company-zoetis-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/adivo-wird-teil-des-weltweit-fuehrenden-unternehmens-fuer-tiergesundheit-zoetis-alumnus-des-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T11:24:27+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/a-management_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/erc-advanced-grant-of-nearly-2-1-million-euros-for-max-planck-director-professor-dr-brenda-schulman-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/erc-advanced-grant-in-hoehe-von-knapp-21-mio-euro-fuer-max-planck-direktorin-prof-dr-brenda-schulman-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/erc-advanced-grant-of-nearly-2-1-million-euros-for-max-planck-director-professor-dr-brenda-schulman-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/erc-advanced-grant-in-hoehe-von-knapp-21-mio-euro-fuer-max-planck-direktorin-prof-dr-brenda-schulman-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T11:24:27+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/brenda-schulman_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/vivoryon-therapeutics-gives-update-on-clinical-development-of-its-lead-candidate-against-alzheimers-disease/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/vivoryon-therapeutics-gibt-update-zur-klinischen-entwicklung-seines-lead-kandidaten-gegen-alzheimer/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/vivoryon-therapeutics-gives-update-on-clinical-development-of-its-lead-candidate-against-alzheimers-disease/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/vivoryon-therapeutics-gibt-update-zur-klinischen-entwicklung-seines-lead-kandidaten-gegen-alzheimer/" />
		<lastmod>2026-07-15T11:24:27+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Vivoryon-2023-03_thumb-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/morphosys-program-tulmimetostat-receives-fda-fast-track-designation-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/morphosys-wirkstoff-tulmimetostat-erhaelt-fast-track-status-der-fda-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/morphosys-program-tulmimetostat-receives-fda-fast-track-designation-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/morphosys-wirkstoff-tulmimetostat-erhaelt-fast-track-status-der-fda-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T11:24:27+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Labor-MorphoSys_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/4scs-resminostat-receives-orphan-drug-designation-from-the-european-medicines-agency-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/4sc-erhaelt-von-der-ema-den-orphan-drug-designation-fuer-resminostat-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/4scs-resminostat-receives-orphan-drug-designation-from-the-european-medicines-agency-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/4sc-erhaelt-von-der-ema-den-orphan-drug-designation-fuer-resminostat-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T11:24:27+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/4SC_cancer-treatment_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/biotech-report-by-vfa-biopharmaceuticals-successfully-gain-market-share-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/biotech-report-der-vfa-biopharmazeutika-steigern-erfolgreich-marktanteil-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/biotech-report-by-vfa-biopharmaceuticals-successfully-gain-market-share-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/biotech-report-der-vfa-biopharmazeutika-steigern-erfolgreich-marktanteil-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T11:24:37+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/biotech-report-titelseite_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/scirhom-announces-first-dosing-in-first-in-man-trial-for-lead-program-sr-878/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/scirhom-kuendigt-die-erste-dosierung-fuer-das-fuehrende-programm-sr-878-an/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/scirhom-announces-first-dosing-in-first-in-man-trial-for-lead-program-sr-878/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/scirhom-kuendigt-die-erste-dosierung-fuer-das-fuehrende-programm-sr-878-an/" />
		<lastmod>2026-07-15T11:24:38+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/iStock-1148000268_istock_monkeybusinessimages_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/thermosomes-lead-compound-the001-shows-promising-initial-clinical-data-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/thermosomes-fuehrender-wirkstoffkandidat-the001-zeigt-vielversprechende-erste-klinische-daten-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/thermosomes-lead-compound-the001-shows-promising-initial-clinical-data-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/thermosomes-fuehrender-wirkstoffkandidat-the001-zeigt-vielversprechende-erste-klinische-daten-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T11:24:38+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/iStock_Ivan-balvan_Thermosome_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/eisbach-bio-announces-first-patient-dosed/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/eisbach-bio-gibt-die-dosierung-der-ersten-patientin-in-der-phase-1-2-studie-fuer-eis-12656-bekannt/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/eisbach-bio-announces-first-patient-dosed/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/eisbach-bio-gibt-die-dosierung-der-ersten-patientin-in-der-phase-1-2-studie-fuer-eis-12656-bekannt/" />
		<lastmod>2026-07-15T11:24:38+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/iStock-1463320057_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/prof-corinna-dawid-leads-leibniz-lsbtum-into-the-future/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/prof-corinna-dawid-leitet-das-leibniz-lsbtum/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/prof-corinna-dawid-leads-leibniz-lsbtum-into-the-future/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/prof-corinna-dawid-leitet-das-leibniz-lsbtum/" />
		<lastmod>2026-07-15T11:24:46+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Prof.-Dr.-Corinna-Dawid_Leibniz-Institut_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/biotech-report-der-vfa-biopharmazeutika-steigern-erfolgreich-marktanteil-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/biotech-report-der-vfa-biopharmazeutika-steigern-erfolgreich-marktanteil-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/biotech-report-by-vfa-biopharmaceuticals-successfully-gain-market-share-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/biotech-report-der-vfa-biopharmazeutika-steigern-erfolgreich-marktanteil-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T11:24:59+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/biotech-report-titelseite_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/scirhom-kuendigt-die-erste-dosierung-fuer-das-fuehrende-programm-sr-878-an/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/scirhom-kuendigt-die-erste-dosierung-fuer-das-fuehrende-programm-sr-878-an/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/scirhom-announces-first-dosing-in-first-in-man-trial-for-lead-program-sr-878/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/scirhom-kuendigt-die-erste-dosierung-fuer-das-fuehrende-programm-sr-878-an/" />
		<lastmod>2026-07-15T11:24:59+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/iStock-1148000268_istock_monkeybusinessimages_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/eisbach-bio-gibt-die-dosierung-der-ersten-patientin-in-der-phase-1-2-studie-fuer-eis-12656-bekannt/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/eisbach-bio-gibt-die-dosierung-der-ersten-patientin-in-der-phase-1-2-studie-fuer-eis-12656-bekannt/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/eisbach-bio-announces-first-patient-dosed/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/eisbach-bio-gibt-die-dosierung-der-ersten-patientin-in-der-phase-1-2-studie-fuer-eis-12656-bekannt/" />
		<lastmod>2026-07-15T11:24:59+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/iStock-1463320057_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/thermosomes-fuehrender-wirkstoffkandidat-the001-zeigt-vielversprechende-erste-klinische-daten-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/thermosomes-fuehrender-wirkstoffkandidat-the001-zeigt-vielversprechende-erste-klinische-daten-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/thermosomes-lead-compound-the001-shows-promising-initial-clinical-data-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/thermosomes-fuehrender-wirkstoffkandidat-the001-zeigt-vielversprechende-erste-klinische-daten-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T11:25:00+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/iStock_Ivan-balvan_Thermosome_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/immunic-praesentierte-in-einem-fe-webcast-zu-multipler-sklerose-neue-daten-zu-ihrem-hauptprodukt-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/immunic-praesentierte-in-einem-fe-webcast-zu-multipler-sklerose-neue-daten-zu-ihrem-hauptprodukt-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/immunic-praesentierte-in-einem-fe-webcast-zu-multipler-sklerose-neue-daten-zu-ihrem-hauptprodukt-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T11:40:49+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Immunic_Team.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/immunic-sichert-sich-60-mio-usd-pipe-finanzierung/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/immunic-sichert-sich-60-mio-usd-pipe-finanzierung/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/immunic-secures-usd-60-million-pipe-financing/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/immunic-sichert-sich-60-mio-usd-pipe-finanzierung/" />
		<lastmod>2026-07-15T11:47:50+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/immunic-gl.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/insempra-beruft-zwei-neue-mitglieder-in-seinen-wissenschaftlichen-beirat/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/insempra-beruft-zwei-neue-mitglieder-in-seinen-wissenschaftlichen-beirat/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/insempra-appoints-two-new-members-to-its-scientific-advisory-board/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/insempra-beruft-zwei-neue-mitglieder-in-seinen-wissenschaftlichen-beirat/" />
		<lastmod>2026-07-15T11:56:53+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/insempra-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/adivo-erhaelt-25-mio-euro-eu-foerderung/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/adivo-erhaelt-25-mio-euro-eu-foerderung/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/adivo-receives-euro-25-million-eu-grant/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/adivo-erhaelt-25-mio-euro-eu-foerderung/" />
		<lastmod>2026-07-15T11:58:09+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/adivo-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/550-jahre-lmu-medizin/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/550-jahre-lmu-medizin/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/550-years-of-lmu-medicine/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/550-jahre-lmu-medizin/" />
		<lastmod>2026-07-15T11:58:58+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/festakt-550-jahre-lmu.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/550-years-of-lmu-medicine/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/550-jahre-lmu-medizin/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/550-years-of-lmu-medicine/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/550-jahre-lmu-medizin/" />
		<lastmod>2026-07-15T11:59:09+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/festakt-550-jahre-lmu.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/prof-dr-petra-schwille-direktorin-am-max-planck-institut-fuer-biochemie-in-martinsried-mit-otto-warburg-medaille-ausgezeichnet/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/prof-dr-petra-schwille-direktorin-am-max-planck-institut-fuer-biochemie-in-martinsried-mit-otto-warburg-medaille-ausgezeichnet/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/professor-petra-schwille-director-at-the-max-planck-institute-of-biochemistry-in-martinsried-awarded-with-otto-warburg-medal/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/prof-dr-petra-schwille-direktorin-am-max-planck-institut-fuer-biochemie-in-martinsried-mit-otto-warburg-medaille-ausgezeichnet/" />
		<lastmod>2026-07-15T11:59:56+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/petra-schwille-izb-biotech-news.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/professor-petra-schwille-director-at-the-max-planck-institute-of-biochemistry-in-martinsried-awarded-with-otto-warburg-medal/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/prof-dr-petra-schwille-direktorin-am-max-planck-institut-fuer-biochemie-in-martinsried-mit-otto-warburg-medaille-ausgezeichnet/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/professor-petra-schwille-director-at-the-max-planck-institute-of-biochemistry-in-martinsried-awarded-with-otto-warburg-medal/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/prof-dr-petra-schwille-direktorin-am-max-planck-institut-fuer-biochemie-in-martinsried-mit-otto-warburg-medaille-ausgezeichnet/" />
		<lastmod>2026-07-15T12:00:17+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/petra-schwille-izb-biotech-news.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/leon-nanodrugs-schliesst-serie-d-finanzierung-ab/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/leon-nanodrugs-schliesst-serie-d-finanzierung-ab/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/leon-nanodrugs-secures-funds-in-a-series-d-financing/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/leon-nanodrugs-schliesst-serie-d-finanzierung-ab/" />
		<lastmod>2026-07-15T12:14:37+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/10/LEON-Portrait_Christian-Nafe_1080x667.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/catalym-kuendigt-neue-finanzierung-in-hoehe-von-150-mio-an-um-ein-breit-angelegtes-phase-2b-entwicklungsprogramm-fuer-visugromab-zu-unterstuetzen/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/catalym-kuendigt-neue-finanzierung-in-hoehe-von-150-mio-an-um-ein-breit-angelegtes-phase-2b-entwicklungsprogramm-fuer-visugromab-zu-unterstuetzen/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/catalym-announces-new-financing-of-150m-to-support-broad-phase-2b-development-program-for-visugromab/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/catalym-kuendigt-neue-finanzierung-in-hoehe-von-150-mio-an-um-ein-breit-angelegtes-phase-2b-entwicklungsprogramm-fuer-visugromab-zu-unterstuetzen/" />
		<lastmod>2026-07-15T12:14:57+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/07/CatalYm_24-07_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/scirhom-sichert-sich-eine-63-mio-e-serie-a-finanzierung-zur-beschleunigten-entwicklung-von-irhom2-therapien-bei-autoimmunkrankheiten/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/scirhom-sichert-sich-eine-63-mio-e-serie-a-finanzierung-zur-beschleunigten-entwicklung-von-irhom2-therapien-bei-autoimmunkrankheiten/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/scirhom-secures-eur-63-million-series-a-financing-round-to-accelerate-irhom2-targeting-therapies-in-autoimmune-diseases/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/scirhom-sichert-sich-eine-63-mio-e-serie-a-finanzierung-zur-beschleunigten-entwicklung-von-irhom2-therapien-bei-autoimmunkrankheiten/" />
		<lastmod>2026-07-15T12:15:06+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/08/SciRhom_Foto_Management_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/scirhom-erhaelt-genehmigung-des-ersten-antrags-fuer-eine-klinische-studie/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/scirhom-erhaelt-genehmigung-des-ersten-antrags-fuer-eine-klinische-studie/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/scirhom-receives-approval-for-first-clinical-trial-application/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/scirhom-erhaelt-genehmigung-des-ersten-antrags-fuer-eine-klinische-studie/" />
		<lastmod>2026-07-15T12:15:13+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/08/post-scirhom.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/thermosome-ernennt-dr-sabine-hauck-zur-chief-technology-officer/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/thermosome-ernennt-dr-sabine-hauck-zur-chief-technology-officer/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/thermosome-appoints-dr-hauck-as-chief-technical-officer/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/thermosome-ernennt-dr-sabine-hauck-zur-chief-technology-officer/" />
		<lastmod>2026-07-15T12:15:18+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/08/haukpost-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/eisbach-erhaelt-45-mio-us-dollar-vom-cancer-focus-fund-zur-durchfuehrung-einer-phase-1-2-studie-mit-dem-fuehrenden-medikamentenkandidaten-eis-12656/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/eisbach-erhaelt-45-mio-us-dollar-vom-cancer-focus-fund-zur-durchfuehrung-einer-phase-1-2-studie-mit-dem-fuehrenden-medikamentenkandidaten-eis-12656/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/eisbach-receives-usd-4-5-million-investment-from-cancer-focus-fund-to-support-phase-1-2-trial-of-lead-candidate-eis-12656-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/eisbach-erhaelt-45-mio-us-dollar-vom-cancer-focus-fund-zur-durchfuehrung-einer-phase-1-2-studie-mit-dem-fuehrenden-medikamentenkandidaten-eis-12656/" />
		<lastmod>2026-07-15T12:17:48+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/08/iStock-487654700_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/morphosys-schliesst-vereinbarung-zur-uebernahme-durch-pharmakonzern-novartis/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/morphosys-schliesst-vereinbarung-zur-uebernahme-durch-pharmakonzern-novartis/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/morphosys-enters-into-business-combination-agreement-to-be-acquired-by-medicines-company-novartis/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/morphosys-schliesst-vereinbarung-zur-uebernahme-durch-pharmakonzern-novartis/" />
		<lastmod>2026-07-15T12:18:13+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/08/Labor-MorphoSys_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/thermosome-erhaelt-behoerdliche-genehmigung-fuer-erste-studie-am-menschen-mit-hauptprogramm-the001/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/thermosome-erhaelt-behoerdliche-genehmigung-fuer-erste-studie-am-menschen-mit-hauptprogramm-the001/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/thermosomes-lead-program-the001-receives-regulatory-approval-for-first-in-human-trial/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/thermosome-erhaelt-behoerdliche-genehmigung-fuer-erste-studie-am-menschen-mit-hauptprogramm-the001/" />
		<lastmod>2026-07-15T12:21:34+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/10/tehrmosome-rendering-1.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/fortbildungsveranstaltungen-fuer-projektleiter-und-beauftragte-fuer-biologische-sicherheit/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/fortbildungsveranstaltungen-fuer-projektleiter-und-beauftragte-fuer-biologische-sicherheit/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/training-events-for-project-managers-and-biological-safety-officers/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/fortbildungsveranstaltungen-fuer-projektleiter-und-beauftragte-fuer-biologische-sicherheit/" />
		<lastmod>2026-07-15T12:21:38+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/DNA-Analyse-auf-moderer-Schnittstelle_thumb.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/catalym-schliesst-ueberzeichnete-serie-c-finanzierung-ueber-50-mio-euro-ab-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/catalym-schliesst-ueberzeichnete-serie-c-finanzierung-ueber-50-mio-euro-ab-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/catalym-raises-eur-50-million-in-oversubscribed-series-c-financing-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/catalym-schliesst-ueberzeichnete-serie-c-finanzierung-ueber-50-mio-euro-ab-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T12:22:49+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Dr.-Phil-LHuillier-Chief-Executive-Officer-bei-CatalYm.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/leon-nanodrugs-secures-funds-in-a-series-d-financing/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/leon-nanodrugs-schliesst-serie-d-finanzierung-ab/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/leon-nanodrugs-secures-funds-in-a-series-d-financing/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/leon-nanodrugs-schliesst-serie-d-finanzierung-ab/" />
		<lastmod>2026-07-15T12:25:42+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/10/LEON-Portrait_Christian-Nafe_1080x667.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/catalym-announces-new-financing-of-150m-to-support-broad-phase-2b-development-program-for-visugromab/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/catalym-kuendigt-neue-finanzierung-in-hoehe-von-150-mio-an-um-ein-breit-angelegtes-phase-2b-entwicklungsprogramm-fuer-visugromab-zu-unterstuetzen/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/catalym-announces-new-financing-of-150m-to-support-broad-phase-2b-development-program-for-visugromab/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/catalym-kuendigt-neue-finanzierung-in-hoehe-von-150-mio-an-um-ein-breit-angelegtes-phase-2b-entwicklungsprogramm-fuer-visugromab-zu-unterstuetzen/" />
		<lastmod>2026-07-15T12:25:57+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/07/CatalYm_24-07_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/scirhom-secures-eur-63-million-series-a-financing-round-to-accelerate-irhom2-targeting-therapies-in-autoimmune-diseases/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/scirhom-sichert-sich-eine-63-mio-e-serie-a-finanzierung-zur-beschleunigten-entwicklung-von-irhom2-therapien-bei-autoimmunkrankheiten/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/scirhom-secures-eur-63-million-series-a-financing-round-to-accelerate-irhom2-targeting-therapies-in-autoimmune-diseases/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/scirhom-sichert-sich-eine-63-mio-e-serie-a-finanzierung-zur-beschleunigten-entwicklung-von-irhom2-therapien-bei-autoimmunkrankheiten/" />
		<lastmod>2026-07-15T12:26:38+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/08/SciRhom_Foto_Management_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/scirhom-receives-approval-for-first-clinical-trial-application/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/scirhom-erhaelt-genehmigung-des-ersten-antrags-fuer-eine-klinische-studie/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/scirhom-receives-approval-for-first-clinical-trial-application/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/scirhom-erhaelt-genehmigung-des-ersten-antrags-fuer-eine-klinische-studie/" />
		<lastmod>2026-07-15T12:26:47+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/08/post-scirhom.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/morphosys-enters-into-business-combination-agreement-to-be-acquired-by-medicines-company-novartis/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/morphosys-schliesst-vereinbarung-zur-uebernahme-durch-pharmakonzern-novartis/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/morphosys-enters-into-business-combination-agreement-to-be-acquired-by-medicines-company-novartis/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/morphosys-schliesst-vereinbarung-zur-uebernahme-durch-pharmakonzern-novartis/" />
		<lastmod>2026-07-15T12:27:40+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/08/Labor-MorphoSys_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/izb-connects-with-shanghai-zhangjiang-hi-tech-park/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/izb-vernetzt-sich-mit-dem-shanghai-zhangjiang-hi-tech-park/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/izb-connects-with-shanghai-zhangjiang-hi-tech-park/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/izb-vernetzt-sich-mit-dem-shanghai-zhangjiang-hi-tech-park/" />
		<lastmod>2026-07-15T12:30:23+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/IZB_Zhangjiang_SCG_180323_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/adivo-expands-into-new-headquarters-as-first-clinical-study-begins/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/adivo-zieht-in-neuen-hauptsitz-und-startet-erste-klinische-studie/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/adivo-expands-into-new-headquarters-as-first-clinical-study-begins/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/adivo-zieht-in-neuen-hauptsitz-und-startet-erste-klinische-studie/" />
		<lastmod>2026-07-15T12:30:57+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/10/adivo-post-fuck-cancer.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/thermosomes-lead-program-the001-receives-regulatory-approval-for-first-in-human-trial/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/thermosome-erhaelt-behoerdliche-genehmigung-fuer-erste-studie-am-menschen-mit-hauptprogramm-the001/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/thermosomes-lead-program-the001-receives-regulatory-approval-for-first-in-human-trial/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/thermosome-erhaelt-behoerdliche-genehmigung-fuer-erste-studie-am-menschen-mit-hauptprogramm-the001/" />
		<lastmod>2026-07-15T12:31:04+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/10/tehrmosome-rendering-1.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/training-events-for-project-managers-and-biological-safety-officers/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/fortbildungsveranstaltungen-fuer-projektleiter-und-beauftragte-fuer-biologische-sicherheit/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/training-events-for-project-managers-and-biological-safety-officers/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/fortbildungsveranstaltungen-fuer-projektleiter-und-beauftragte-fuer-biologische-sicherheit/" />
		<lastmod>2026-07-15T12:31:10+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/DNA-Analyse-auf-moderer-Schnittstelle_thumb-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/christian-pangratz-becomes-new-ceo-of-atriva-therapeutics/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/christian-pangratz-wird-neuer-ceo-von-atriva-therapeutics-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/christian-pangratz-becomes-new-ceo-of-atriva-therapeutics/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/christian-pangratz-wird-neuer-ceo-von-atriva-therapeutics-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T12:31:35+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/10/christian-pangratz_gross2.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/catalym-raises-eur-50-million-in-oversubscribed-series-c-financing-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/catalym-schliesst-ueberzeichnete-serie-c-finanzierung-ueber-50-mio-euro-ab-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/catalym-raises-eur-50-million-in-oversubscribed-series-c-financing-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/catalym-schliesst-ueberzeichnete-serie-c-finanzierung-ueber-50-mio-euro-ab-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T12:31:56+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Dr.-Phil-LHuillier-Chief-Executive-Officer-bei-CatalYm.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/campus-hotel-restaurants-und-faculty-club-wieder-geoeffnet/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/campus-hotel-restaurants-und-faculty-club-wieder-geoeffnet/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/campus-hotel-restaurants-und-faculty-club-wieder-geoeffnet/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/campus-hotel-restaurants-und-faculty-club-wieder-geoeffnet/" />
		<lastmod>2026-07-15T12:47:39+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/facults-club02.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/m1-munich-medicine-alliance-weichenstellung-um-deutschlands-medizinstandort-nr-1-zu-werden-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/m1-munich-medicine-alliance-weichenstellung-um-deutschlands-medizinstandort-nr-1-zu-werden-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/m1-munich-medical-alliance-becoming-germanys-no-1-medical-location-innovations-und-grunderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/m1-munich-medicine-alliance-weichenstellung-um-deutschlands-medizinstandort-nr-1-zu-werden-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-15T14:47:55+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/20230717_Medizin-Gipfel_KD-31_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/rna-technologie-koennte-gegen-knochenschwund-helfen/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/rna-technologie-koennte-gegen-knochenschwund-helfen/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/rna-technology-could-help-fight-bone-loss/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/rna-technologie-koennte-gegen-knochenschwund-helfen/" />
		<lastmod>2026-07-15T14:48:17+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/osteoporose.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/nachwuchswissenschaftlerinnen-vom-max-planck-institut-fuer-biologische-intelligenz-mit-young-scientist-award-ausgezeichnet/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/nachwuchswissenschaftlerinnen-vom-max-planck-institut-fuer-biologische-intelligenz-mit-young-scientist-award-ausgezeichnet/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/junior-female-scientists-from-the-max-planck-institute-for-biological-intelligence-honored-with-young-scientist-award/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/nachwuchswissenschaftlerinnen-vom-max-planck-institut-fuer-biologische-intelligenz-mit-young-scientist-award-ausgezeichnet/" />
		<lastmod>2026-07-15T15:11:53+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/YoungScientistsAward.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/secarna-pharmaceuticals-and-scineuro-pharmaceuticals-partner-to-develop-therapies-for-cns-diseases/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/secarna-pharmaceuticals-und-scineuro-pharmaceuticals-schliessen-partnerschaft-zur-entwicklung-von-therapien-fuer-zns-erkrankungen/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/secarna-pharmaceuticals-and-scineuro-pharmaceuticals-partner-to-develop-therapies-for-cns-diseases/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/secarna-pharmaceuticals-und-scineuro-pharmaceuticals-schliessen-partnerschaft-zur-entwicklung-von-therapien-fuer-zns-erkrankungen/" />
		<lastmod>2026-07-15T15:22:36+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Secarna_SciNeuro_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/secarna-pharmaceuticals-und-scineuro-pharmaceuticals-schliessen-partnerschaft-zur-entwicklung-von-therapien-fuer-zns-erkrankungen/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/secarna-pharmaceuticals-und-scineuro-pharmaceuticals-schliessen-partnerschaft-zur-entwicklung-von-therapien-fuer-zns-erkrankungen/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/secarna-pharmaceuticals-and-scineuro-pharmaceuticals-partner-to-develop-therapies-for-cns-diseases/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/secarna-pharmaceuticals-und-scineuro-pharmaceuticals-schliessen-partnerschaft-zur-entwicklung-von-therapien-fuer-zns-erkrankungen/" />
		<lastmod>2026-07-15T15:22:52+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Secarna_SciNeuro_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/atriva-therapeutics-meldet-exklusive-absichtserklaerung-fuer-reverse-takeover-transaktion-mit-biocure-technology-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/atriva-therapeutics-meldet-exklusive-absichtserklaerung-fuer-reverse-takeover-transaktion-mit-biocure-technology-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/atriva-therapeutics-announces-exclusive-letter-agreement-for-reverse-takeover-transaction-with-biocure-technology-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/atriva-therapeutics-meldet-exklusive-absichtserklaerung-fuer-reverse-takeover-transaktion-mit-biocure-technology-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:15+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Atriva-boersengelistet_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/christian-pangratz-wird-neuer-ceo-von-atriva-therapeutics-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/christian-pangratz-wird-neuer-ceo-von-atriva-therapeutics-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/christian-pangratz-becomes-new-ceo-of-atriva-therapeutics/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/christian-pangratz-wird-neuer-ceo-von-atriva-therapeutics-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:18+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/10/christian-pangratz_gross2.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/chromotek-begruesst-rainer-gebhart-als-neuen-niederlassungsleiter-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/chromotek-begruesst-rainer-gebhart-als-neuen-niederlassungsleiter-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/chromotek-welcomes-rainer-gebhart-as-new-site-manager-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/chromotek-begruesst-rainer-gebhart-als-neuen-niederlassungsleiter-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:19+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Rainer-Gebhart_neuer-Niederlassungsleiter_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/das-zebrafischgehirn-als-interaktive-karte-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/das-zebrafischgehirn-als-interaktive-karte-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/the-zebrafish-brain-as-a-map-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/das-zebrafischgehirn-als-interaktive-karte-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:19+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/10/zebrafische_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/eisbach-startet-klinische-phase-1-studie-mit-covid-19-virostatikum-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/eisbach-startet-klinische-phase-1-studie-mit-covid-19-virostatikum-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/eisbach-startet-klinische-phase-1-studie-mit-covid-19-virostatikum-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:20+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Dr.-Adrian-Schomburg-CEO-Eisbach-Bio-GmbH-2000x1098-1.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/enno-spillner-wird-neuer-cfo-bei-formycon-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/enno-spillner-wird-neuer-cfo-bei-formycon-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/enno-spillner-to-join-formycon-as-cfo-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/enno-spillner-wird-neuer-cfo-bei-formycon-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:21+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/10/Enno-Spillner_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/goingpublic-feiert-ein-vierteljahrhundert-biotech-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/goingpublic-feiert-ein-vierteljahrhundert-biotech-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/goingpublic-celebrates-a-quarter-century-of-biotech-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/goingpublic-feiert-ein-vierteljahrhundert-biotech-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:22+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/1_MAR8027_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/hochkaraetiger-klinischer-beirat-fuer-thermosome-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/hochkaraetiger-klinischer-beirat-fuer-thermosome-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/high-profile-clinical-advisory-board-for-thermosome-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/hochkaraetiger-klinischer-beirat-fuer-thermosome-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:23+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Montage_Lars-Lindner_Pascal-Schweizer_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/insempra-bringt-seinen-ersten-funktionalen-inhaltsstoff-fuer-konsumgueter-auf-den-markt-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/insempra-bringt-seinen-ersten-funktionalen-inhaltsstoff-fuer-konsumgueter-auf-den-markt-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/insempra-launches-its-first-functional-component-for-consumer-goods-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/insempra-bringt-seinen-ersten-funktionalen-inhaltsstoff-fuer-konsumgueter-auf-den-markt-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:24+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Insempra_Himbeere_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/insempra-ernennt-neuen-chief-operating-officer-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/insempra-ernennt-neuen-chief-operating-officer-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/insempra-names-new-chief-operating-officer-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/insempra-ernennt-neuen-chief-operating-officer-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:25+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/10/Lin-Roemer_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/neue-praeklinische-daten-zeigen-dauerhafte-antitumoreffekte-von-secarna-pharmaceuticals-antisense-oligonukleotid-aso-therapien-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/neue-praeklinische-daten-zeigen-dauerhafte-antitumoreffekte-von-secarna-pharmaceuticals-antisense-oligonukleotid-aso-therapien-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/new-preclinical-data-show-long-term-antitumor-effects-of-secarna-pharmaceuticals-antisense-oligonucleotide-aso-therapies-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/neue-praeklinische-daten-zeigen-dauerhafte-antitumoreffekte-von-secarna-pharmaceuticals-antisense-oligonukleotid-aso-therapien-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:28+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Secarna_Boesartige-Krebszellen-unter-Mikroskop_200x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/morphosys-beendet-eigene-praeklinische-forschungsprogramme-und-optimiert-weiter-kostenstruktur-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/morphosys-beendet-eigene-praeklinische-forschungsprogramme-und-optimiert-weiter-kostenstruktur-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/morphosys-stops-proprietary-pre-clinical-research-programs-and-further-optimizes-cost-structure-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/morphosys-beendet-eigene-praeklinische-forschungsprogramme-und-optimiert-weiter-kostenstruktur-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:28+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/10/MorphoSys-Gebaeude.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/scirhom-reicht-antrag-fuer-erste-klinische-studien-am-menschen-mit-dem-wirkstoffkandidaten-sr-878-ein-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/scirhom-reicht-antrag-fuer-erste-klinische-studien-am-menschen-mit-dem-wirkstoffkandidaten-sr-878-ein-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/scirhom-submits-clinical-trial-application-for-first-in-human-trials-with-lead-candidate-sr-878-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/scirhom-reicht-antrag-fuer-erste-klinische-studien-am-menschen-mit-dem-wirkstoffkandidaten-sr-878-ein-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:32+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/shutterstock_1736709881_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/suessstoffe-koennen-das-menschliche-immunsystem-beeinflussen-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/suessstoffe-koennen-das-menschliche-immunsystem-beeinflussen-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/non-nutritive-sweeteners-may-affect-the-human-immune-system-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/suessstoffe-koennen-das-menschliche-immunsystem-beeinflussen-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:34+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Leibniz-Institut_Immunzellen-und-Suessstoffe_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/us-unternehmen-neuron23-startet-klinische-phase-1-studie-zur-behandlung-von-parkinson-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/us-unternehmen-neuron23-startet-klinische-phase-1-studie-zur-behandlung-von-parkinson-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/us-based-neuron23-starts-phase-1-clinical-trial-in-parkinsons-disease-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/us-unternehmen-neuron23-startet-klinische-phase-1-studie-zur-behandlung-von-parkinson-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:35+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/10/neuron23_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/atriva-therapeutics-announces-exclusive-letter-agreement-for-reverse-takeover-transaction-with-biocure-technology-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/atriva-therapeutics-meldet-exklusive-absichtserklaerung-fuer-reverse-takeover-transaktion-mit-biocure-technology-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/atriva-therapeutics-announces-exclusive-letter-agreement-for-reverse-takeover-transaction-with-biocure-technology-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/atriva-therapeutics-meldet-exklusive-absichtserklaerung-fuer-reverse-takeover-transaktion-mit-biocure-technology-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:40+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Atriva-boersengelistet_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/chromotek-welcomes-rainer-gebhart-as-new-site-manager-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/chromotek-begruesst-rainer-gebhart-als-neuen-niederlassungsleiter-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/chromotek-welcomes-rainer-gebhart-as-new-site-manager-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/chromotek-begruesst-rainer-gebhart-als-neuen-niederlassungsleiter-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:41+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Rainer-Gebhart_neuer-Niederlassungsleiter_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/eisbach-receives-usd-4-5-million-investment-from-cancer-focus-fund-to-support-phase-1-2-trial-of-lead-candidate-eis-12656-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/eisbach-erhaelt-45-mio-us-dollar-vom-cancer-focus-fund-zur-durchfuehrung-einer-phase-1-2-studie-mit-dem-fuehrenden-medikamentenkandidaten-eis-12656/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/eisbach-receives-usd-4-5-million-investment-from-cancer-focus-fund-to-support-phase-1-2-trial-of-lead-candidate-eis-12656-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/eisbach-erhaelt-45-mio-us-dollar-vom-cancer-focus-fund-zur-durchfuehrung-einer-phase-1-2-studie-mit-dem-fuehrenden-medikamentenkandidaten-eis-12656/" />
		<lastmod>2026-07-16T11:04:42+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/08/iStock-487654700_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/eisbach-startet-klinische-phase-1-studie-mit-covid-19-virostatikum-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/eisbach-startet-klinische-phase-1-studie-mit-covid-19-virostatikum-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:43+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Dr.-Adrian-Schomburg-CEO-Eisbach-Bio-GmbH-2000x1098-1.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/enno-spillner-to-join-formycon-as-cfo-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/enno-spillner-wird-neuer-cfo-bei-formycon-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/enno-spillner-to-join-formycon-as-cfo-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/enno-spillner-wird-neuer-cfo-bei-formycon-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:45+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/10/Enno-Spillner_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/high-profile-clinical-advisory-board-for-thermosome-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/hochkaraetiger-klinischer-beirat-fuer-thermosome-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/high-profile-clinical-advisory-board-for-thermosome-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/hochkaraetiger-klinischer-beirat-fuer-thermosome-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:46+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Montage_Lars-Lindner_Pascal-Schweizer_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/insempra-launches-its-first-functional-component-for-consumer-goods-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/insempra-bringt-seinen-ersten-funktionalen-inhaltsstoff-fuer-konsumgueter-auf-den-markt-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/insempra-launches-its-first-functional-component-for-consumer-goods-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/insempra-bringt-seinen-ersten-funktionalen-inhaltsstoff-fuer-konsumgueter-auf-den-markt-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:47+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Insempra_Himbeere_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/insempra-names-new-chief-operating-officer-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/insempra-ernennt-neuen-chief-operating-officer-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/insempra-names-new-chief-operating-officer-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/insempra-ernennt-neuen-chief-operating-officer-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:48+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/10/Lin-Roemer_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/invitris-receives-250000-eur-to-complete-spin-out-from-tum-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/invitris-erhaelt-250-000-euro-fuer-vollstaendige-ausgruendung-aus-der-tum-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/invitris-receives-250000-eur-to-complete-spin-out-from-tum-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/invitris-erhaelt-250-000-euro-fuer-vollstaendige-ausgruendung-aus-der-tum-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:49+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Invitris_TUM_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/morphosys-stops-proprietary-pre-clinical-research-programs-and-further-optimizes-cost-structure-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/morphosys-beendet-eigene-praeklinische-forschungsprogramme-und-optimiert-weiter-kostenstruktur-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/morphosys-stops-proprietary-pre-clinical-research-programs-and-further-optimizes-cost-structure-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/morphosys-beendet-eigene-praeklinische-forschungsprogramme-und-optimiert-weiter-kostenstruktur-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:54+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/10/MorphoSys-Gebaeude.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/new-preclinical-data-show-long-term-antitumor-effects-of-secarna-pharmaceuticals-antisense-oligonucleotide-aso-therapies-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/neue-praeklinische-daten-zeigen-dauerhafte-antitumoreffekte-von-secarna-pharmaceuticals-antisense-oligonukleotid-aso-therapien-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/new-preclinical-data-show-long-term-antitumor-effects-of-secarna-pharmaceuticals-antisense-oligonucleotide-aso-therapies-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/neue-praeklinische-daten-zeigen-dauerhafte-antitumoreffekte-von-secarna-pharmaceuticals-antisense-oligonukleotid-aso-therapien-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:56+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Secarna_Boesartige-Krebszellen-unter-Mikroskop_200x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/non-nutritive-sweeteners-may-affect-the-human-immune-system-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/suessstoffe-koennen-das-menschliche-immunsystem-beeinflussen-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/non-nutritive-sweeteners-may-affect-the-human-immune-system-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/suessstoffe-koennen-das-menschliche-immunsystem-beeinflussen-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:57+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Leibniz-Institut_Immunzellen-und-Suessstoffe_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/scirhom-submits-clinical-trial-application-for-first-in-human-trials-with-lead-candidate-sr-878-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/scirhom-reicht-antrag-fuer-erste-klinische-studien-am-menschen-mit-dem-wirkstoffkandidaten-sr-878-ein-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/scirhom-submits-clinical-trial-application-for-first-in-human-trials-with-lead-candidate-sr-878-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/scirhom-reicht-antrag-fuer-erste-klinische-studien-am-menschen-mit-dem-wirkstoffkandidaten-sr-878-ein-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:04:59+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/shutterstock_1736709881_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/specific-packaging-of-dna-affects-cell-division-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/spezifische-verpackung-der-dna-beeinflusst-die-zellteilung-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/specific-packaging-of-dna-affects-cell-division-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/spezifische-verpackung-der-dna-beeinflusst-die-zellteilung-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:05:04+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Dr.-Christoph-Kurat-Erika-Chacin_ID26208_1000x667.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/the-zebrafish-brain-as-a-map-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/das-zebrafischgehirn-als-interaktive-karte-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/the-zebrafish-brain-as-a-map-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/das-zebrafischgehirn-als-interaktive-karte-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:05:05+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/10/zebrafische_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/us-based-neuron23-starts-phase-1-clinical-trial-in-parkinsons-disease-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/us-unternehmen-neuron23-startet-klinische-phase-1-studie-zur-behandlung-von-parkinson-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/us-based-neuron23-starts-phase-1-clinical-trial-in-parkinsons-disease-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/us-unternehmen-neuron23-startet-klinische-phase-1-studie-zur-behandlung-von-parkinson-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:05:07+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/10/neuron23_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/adivos-erstes-onkologie-programm-erhaelt-eingeschraenkte-marktzulassung-von-der-ema-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/adivos-erstes-onkologie-programm-erhaelt-eingeschraenkte-marktzulassung-von-der-ema-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/adivos-erstes-onkologie-programm-erhaelt-eingeschraenkte-marktzulassung-von-der-ema/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/adivos-erstes-onkologie-programm-erhaelt-eingeschraenkte-marktzulassung-von-der-ema-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:05:09+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/adivo-onkologie-programm.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/amsilk-erweitert-serie-c-finanzierung-auf-54-mio-euro-unterstuetzt-von-namhaften-investoren-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/amsilk-erweitert-serie-c-finanzierung-auf-54-mio-euro-unterstuetzt-von-namhaften-investoren-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/amsilk-extends-series-c-financing-to-eur-54-million-backed-by-renowned-investors-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/amsilk-erweitert-serie-c-finanzierung-auf-54-mio-euro-unterstuetzt-von-namhaften-investoren-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:05:13+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/AMSilk_Produktion_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/was-das-immunsystem-anfaellig-fuer-toedliche-infektionen-macht/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/was-das-immunsystem-anfaellig-fuer-toedliche-infektionen-macht/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/when-life-begins-too-early/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/was-das-immunsystem-anfaellig-fuer-toedliche-infektionen-macht/" />
		<lastmod>2026-07-16T11:05:16+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Neue-Studie-zu-Fruehgeborenen-thumbnail.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/wirtschaftsempfang-2023-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/wirtschaftsempfang-2023-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/business-reception-2023-innovation-and-founder-center-biotechnology-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/wirtschaftsempfang-2023-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:05:16+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Header-Wirtschaftsempfang_Text_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/adivos-erstes-onkologie-programm-erhaelt-eingeschraenkte-marktzulassung-von-der-ema/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/adivos-erstes-onkologie-programm-erhaelt-eingeschraenkte-marktzulassung-von-der-ema-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/adivos-erstes-onkologie-programm-erhaelt-eingeschraenkte-marktzulassung-von-der-ema/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/adivos-erstes-onkologie-programm-erhaelt-eingeschraenkte-marktzulassung-von-der-ema-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:05:24+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/adivo-onkologie-programm.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/when-life-begins-too-early/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/was-das-immunsystem-anfaellig-fuer-toedliche-infektionen-macht/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/when-life-begins-too-early/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/was-das-immunsystem-anfaellig-fuer-toedliche-infektionen-macht/" />
		<lastmod>2026-07-16T11:05:26+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Neue-Studie-zu-Fruehgeborenen-thumbnail-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/image-video-izb-2025/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/image-video-izb-2025/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/25699/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/image-video-izb-2025/" />
		<lastmod>2026-07-16T11:49:24+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Image-Video-Thumb2.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/m1-munich-medical-alliance-becoming-germanys-no-1-medical-location-innovations-und-grunderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/m1-munich-medicine-alliance-weichenstellung-um-deutschlands-medizinstandort-nr-1-zu-werden-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/m1-munich-medical-alliance-becoming-germanys-no-1-medical-location-innovations-und-grunderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/m1-munich-medicine-alliance-weichenstellung-um-deutschlands-medizinstandort-nr-1-zu-werden-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T11:49:41+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/20230717_Medizin-Gipfel_KD-31_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/thermosome-appoints-dr-hauck-as-chief-technical-officer/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/thermosome-ernennt-dr-sabine-hauck-zur-chief-technology-officer/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/thermosome-appoints-dr-hauck-as-chief-technical-officer/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/thermosome-ernennt-dr-sabine-hauck-zur-chief-technology-officer/" />
		<lastmod>2026-07-16T11:50:00+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/08/haukpost-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/adivo-receives-euro-25-million-eu-grant/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/adivo-erhaelt-25-mio-euro-eu-foerderung/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/adivo-receives-euro-25-million-eu-grant/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/adivo-erhaelt-25-mio-euro-eu-foerderung/" />
		<lastmod>2026-07-16T11:50:09+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/adivo-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/immunic-secures-usd-60-million-pipe-financing/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/immunic-sichert-sich-60-mio-usd-pipe-finanzierung/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/immunic-secures-usd-60-million-pipe-financing/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/immunic-sichert-sich-60-mio-usd-pipe-finanzierung/" />
		<lastmod>2026-07-16T11:50:53+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/immunic-gl.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/insempra-appoints-two-new-members-to-its-scientific-advisory-board/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/insempra-beruft-zwei-neue-mitglieder-in-seinen-wissenschaftlichen-beirat/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/insempra-appoints-two-new-members-to-its-scientific-advisory-board/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/insempra-beruft-zwei-neue-mitglieder-in-seinen-wissenschaftlichen-beirat/" />
		<lastmod>2026-07-16T11:50:58+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/insempra-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/junior-female-scientists-from-the-max-planck-institute-for-biological-intelligence-honored-with-young-scientist-award/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/nachwuchswissenschaftlerinnen-vom-max-planck-institut-fuer-biologische-intelligenz-mit-young-scientist-award-ausgezeichnet/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/junior-female-scientists-from-the-max-planck-institute-for-biological-intelligence-honored-with-young-scientist-award/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/nachwuchswissenschaftlerinnen-vom-max-planck-institut-fuer-biologische-intelligenz-mit-young-scientist-award-ausgezeichnet/" />
		<lastmod>2026-07-16T11:51:17+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/YoungScientistsAward.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/rna-technology-could-help-fight-bone-loss/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/rna-technologie-koennte-gegen-knochenschwund-helfen/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/rna-technology-could-help-fight-bone-loss/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/rna-technologie-koennte-gegen-knochenschwund-helfen/" />
		<lastmod>2026-07-16T11:52:00+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/osteoporose.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/matthias-mann-und-wolfgang-baumeister-gewinnen-gairdner-international-awards-2026/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/matthias-mann-und-wolfgang-baumeister-gewinnen-gairdner-international-awards-2026/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/matthias-mann-and-wolfgang-baumeister-win-gairdner-international-awards-2026/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/matthias-mann-und-wolfgang-baumeister-gewinnen-gairdner-international-awards-2026/" />
		<lastmod>2026-07-16T13:11:45+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Foto_Mann_Baumeister_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/momentum-biotechnologies-uebernimmt-omicscouts-und-erweitert-seine-proteomik-kompetenzen/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/momentum-biotechnologies-uebernimmt-omicscouts-und-erweitert-seine-proteomik-kompetenzen/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/momentum-biotechnologies-acquires-omicscouts-expanding-proteomics-capabilities/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/momentum-biotechnologies-uebernimmt-omicscouts-und-erweitert-seine-proteomik-kompetenzen/" />
		<lastmod>2026-07-16T13:11:46+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/250306_OmicScouts-Uebernahme_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/invitris-fuer-den-eic-accelerator-ausgewaehlt-eine-revolution-in-der-personalisierten-medizin/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/invitris-fuer-den-eic-accelerator-ausgewaehlt-eine-revolution-in-der-personalisierten-medizin/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/invitris-selected-for-eic-accelerator-revolutionizing-personalized-medicine/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/invitris-fuer-den-eic-accelerator-ausgewaehlt-eine-revolution-in-der-personalisierten-medizin/" />
		<lastmod>2026-07-16T13:11:48+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/030325_Invitris-3_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/closing-the-gap-weibliche-fuehrungskraefte-in-der-biotech-branche/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/closing-the-gap-weibliche-fuehrungskraefte-in-der-biotech-branche/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/closing-the-gap-female-leadership-in-biotech/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/closing-the-gap-weibliche-fuehrungskraefte-in-der-biotech-branche/" />
		<lastmod>2026-07-16T13:11:52+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/DSCF3501_IZBrunch-2025_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/biotechnologie-staerken-politischer-austausch-am-izb-zur-zukunft-des-innovationsstandorts-deutschland/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/biotechnologie-staerken-politischer-austausch-am-izb-zur-zukunft-des-innovationsstandorts-deutschland/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/strengthening-biotechnology-political-dialogue-at-izb-on-germanys-innovation-future/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/biotechnologie-staerken-politischer-austausch-am-izb-zur-zukunft-des-innovationsstandorts-deutschland/" />
		<lastmod>2026-07-16T13:11:57+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/1_DSCF4441_Markus-Blume_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/eisbach-bio-erhaelt-cprit-foerderung-fuer-die-klinische-entwicklung-eines-neuen-krebstherapeutikums/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/eisbach-bio-erhaelt-cprit-foerderung-fuer-die-klinische-entwicklung-eines-neuen-krebstherapeutikums/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/eisbach-bio-secures-cprit-grant-to-advance-novel-cancer-therapeutic/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/eisbach-bio-erhaelt-cprit-foerderung-fuer-die-klinische-entwicklung-eines-neuen-krebstherapeutikums/" />
		<lastmod>2026-07-16T13:11:58+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/241203_Eisbach-CPRIT_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/matthias-mann-and-wolfgang-baumeister-win-gairdner-international-awards-2026/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/matthias-mann-und-wolfgang-baumeister-gewinnen-gairdner-international-awards-2026/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/matthias-mann-and-wolfgang-baumeister-win-gairdner-international-awards-2026/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/matthias-mann-und-wolfgang-baumeister-gewinnen-gairdner-international-awards-2026/" />
		<lastmod>2026-07-16T13:12:01+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Foto_Mann_Baumeister_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/momentum-biotechnologies-acquires-omicscouts-expanding-proteomics-capabilities/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/momentum-biotechnologies-uebernimmt-omicscouts-und-erweitert-seine-proteomik-kompetenzen/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/momentum-biotechnologies-acquires-omicscouts-expanding-proteomics-capabilities/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/momentum-biotechnologies-uebernimmt-omicscouts-und-erweitert-seine-proteomik-kompetenzen/" />
		<lastmod>2026-07-16T13:12:04+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/250306_OmicScouts-Uebernahme_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/invitris-selected-for-eic-accelerator-revolutionizing-personalized-medicine/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/invitris-fuer-den-eic-accelerator-ausgewaehlt-eine-revolution-in-der-personalisierten-medizin/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/invitris-selected-for-eic-accelerator-revolutionizing-personalized-medicine/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/invitris-fuer-den-eic-accelerator-ausgewaehlt-eine-revolution-in-der-personalisierten-medizin/" />
		<lastmod>2026-07-16T13:12:07+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/030325_Invitris-3_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/closing-the-gap-female-leadership-in-biotech/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/closing-the-gap-weibliche-fuehrungskraefte-in-der-biotech-branche/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/closing-the-gap-female-leadership-in-biotech/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/closing-the-gap-weibliche-fuehrungskraefte-in-der-biotech-branche/" />
		<lastmod>2026-07-16T13:12:09+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/DSCF3501_IZBrunch-2025_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/strengthening-biotechnology-political-dialogue-at-izb-on-germanys-innovation-future/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/biotechnologie-staerken-politischer-austausch-am-izb-zur-zukunft-des-innovationsstandorts-deutschland/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/strengthening-biotechnology-political-dialogue-at-izb-on-germanys-innovation-future/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/biotechnologie-staerken-politischer-austausch-am-izb-zur-zukunft-des-innovationsstandorts-deutschland/" />
		<lastmod>2026-07-16T13:12:11+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/1_DSCF4441_Markus-Blume_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/eisbach-bio-secures-cprit-grant-to-advance-novel-cancer-therapeutic/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/eisbach-bio-erhaelt-cprit-foerderung-fuer-die-klinische-entwicklung-eines-neuen-krebstherapeutikums/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/eisbach-bio-secures-cprit-grant-to-advance-novel-cancer-therapeutic/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/eisbach-bio-erhaelt-cprit-foerderung-fuer-die-klinische-entwicklung-eines-neuen-krebstherapeutikums/" />
		<lastmod>2026-07-16T13:12:12+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/241203_Eisbach-CPRIT_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/9th-munich-life-science-pitch-day-im-izb-innovationen-treffen-investoren/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/9th-munich-life-science-pitch-day-im-izb-innovationen-treffen-investoren/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/9-munich-life-science-pitch-day-at-the-izb-innovations-meet-investors/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/9th-munich-life-science-pitch-day-im-izb-innovationen-treffen-investoren/" />
		<lastmod>2026-07-16T13:19:04+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/10/pitch-day-24_Networking_1032x687.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/onkologie-experten-unterstuetzen-die-entwicklung-des-wirkstoffkandidaten-the001-von-thermosome-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/onkologie-experten-unterstuetzen-die-entwicklung-des-wirkstoffkandidaten-the001-von-thermosome-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/oncology-experts-to-support-the-development-of-thermosomes-clinical-candidate-the001-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/onkologie-experten-unterstuetzen-die-entwicklung-des-wirkstoffkandidaten-the001-von-thermosome-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T13:19:18+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Gronchi_Hermann_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/das-studierendenwerk-muenchen-oberbayern-besucht-das-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/das-studierendenwerk-muenchen-oberbayern-besucht-das-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/the-munich-bavaria-student-union-visits-the-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/das-studierendenwerk-muenchen-oberbayern-besucht-das-izb/" />
		<lastmod>2026-07-16T13:19:32+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Studierendenwerk_MAR9408_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/gdf-15-neutralisieren-entwicklung-einer-neuen-klasse-von-immuntherapien-zur-krebsbekaempfung/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/gdf-15-neutralisieren-entwicklung-einer-neuen-klasse-von-immuntherapien-zur-krebsbekaempfung/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/neutralizing-gdf-15-development-of-a-new-class-of-anti-cancer-immunotherapy/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/gdf-15-neutralisieren-entwicklung-einer-neuen-klasse-von-immuntherapien-zur-krebsbekaempfung/" />
		<lastmod>2026-07-16T13:19:42+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/CatalYm_Video-Thumb_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/invitris-erhaelt-250-000-euro-fuer-vollstaendige-ausgruendung-aus-der-tum-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/invitris-erhaelt-250-000-euro-fuer-vollstaendige-ausgruendung-aus-der-tum-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/invitris-receives-250000-eur-to-complete-spin-out-from-tum-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/invitris-erhaelt-250-000-euro-fuer-vollstaendige-ausgruendung-aus-der-tum-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T13:20:33+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Invitris_TUM_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/izb-vernetzt-sich-mit-dem-shanghai-zhangjiang-hi-tech-park/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/izb-vernetzt-sich-mit-dem-shanghai-zhangjiang-hi-tech-park/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/izb-connects-with-shanghai-zhangjiang-hi-tech-park/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/izb-vernetzt-sich-mit-dem-shanghai-zhangjiang-hi-tech-park/" />
		<lastmod>2026-07-16T13:20:43+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/IZB_Zhangjiang_SCG_180323_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/spezifische-verpackung-der-dna-beeinflusst-die-zellteilung-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/spezifische-verpackung-der-dna-beeinflusst-die-zellteilung-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/specific-packaging-of-dna-affects-cell-division-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/spezifische-verpackung-der-dna-beeinflusst-die-zellteilung-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-16T13:20:54+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Dr.-Christoph-Kurat-Erika-Chacin_ID26208_1000x667.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/adivo-zieht-in-neuen-hauptsitz-und-startet-erste-klinische-studie/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/adivo-zieht-in-neuen-hauptsitz-und-startet-erste-klinische-studie/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/adivo-expands-into-new-headquarters-as-first-clinical-study-begins/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/adivo-zieht-in-neuen-hauptsitz-und-startet-erste-klinische-studie/" />
		<lastmod>2026-07-16T13:21:02+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/10/adivo-post-fuck-cancer.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/neutralizing-gdf-15-development-of-a-new-class-of-anti-cancer-immunotherapy/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/gdf-15-neutralisieren-entwicklung-einer-neuen-klasse-von-immuntherapien-zur-krebsbekaempfung/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/neutralizing-gdf-15-development-of-a-new-class-of-anti-cancer-immunotherapy/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/gdf-15-neutralisieren-entwicklung-einer-neuen-klasse-von-immuntherapien-zur-krebsbekaempfung/" />
		<lastmod>2026-07-16T14:06:27+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/CatalYm_Video-Thumb_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/campus-hotel-restaurants-und-faculty-club-wieder-geoeffnet/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/campus-hotel-restaurants-und-faculty-club-wieder-geoeffnet/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/campus-hotel-restaurants-und-faculty-club-wieder-geoeffnet/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/campus-hotel-restaurants-und-faculty-club-wieder-geoeffnet/" />
		<lastmod>2026-07-16T15:30:06+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/facults-club02.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/sirion-biotech-auf-expansionskurs-fuer-die-zell-und-gentherapie/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/sirion-biotech-auf-expansionskurs-fuer-die-zell-und-gentherapie/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/sirion-biotech-on-expansion-course-for-cell-and-gene-therapy/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/sirion-biotech-auf-expansionskurs-fuer-die-zell-und-gentherapie/" />
		<lastmod>2026-07-16T15:53:36+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/sirion_event02.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/sirion-biotech-on-expansion-course-for-cell-and-gene-therapy/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/sirion-biotech-auf-expansionskurs-fuer-die-zell-und-gentherapie/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/sirion-biotech-on-expansion-course-for-cell-and-gene-therapy/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/sirion-biotech-auf-expansionskurs-fuer-die-zell-und-gentherapie/" />
		<lastmod>2026-07-16T15:55:44+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/sirion_event02.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/gilead-uebernimmt-tubulis-im-rahmen-einer-5-milliarden-dollar-expansion-im-bereich-adc-onkologie/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/gilead-uebernimmt-tubulis-im-rahmen-einer-5-milliarden-dollar-expansion-im-bereich-adc-onkologie/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/gilead-to-acquire-tubulis-in-5b-adc-oncology-expansion-2/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/gilead-uebernimmt-tubulis-im-rahmen-einer-5-milliarden-dollar-expansion-im-bereich-adc-onkologie/" />
		<lastmod>2026-07-22T07:32:21+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Tubulis_04_22_-07_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/gilead-to-acquire-tubulis-in-5b-adc-oncology-expansion-2/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/gilead-uebernimmt-tubulis-im-rahmen-einer-5-milliarden-dollar-expansion-im-bereich-adc-onkologie/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/gilead-to-acquire-tubulis-in-5b-adc-oncology-expansion-2/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/gilead-uebernimmt-tubulis-im-rahmen-einer-5-milliarden-dollar-expansion-im-bereich-adc-onkologie/" />
		<lastmod>2026-07-22T07:56:59+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Tubulis_04_22_-07_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/catalym-behandelt-ersten-patienten-in-phase-2b-studie-zur-bewertung-von-visugromab-in-kombination-mit-chemoimmuntherapie-bei-nicht-plattenepithelialem-nsclc/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/catalym-behandelt-ersten-patienten-in-phase-2b-studie-zur-bewertung-von-visugromab-in-kombination-mit-chemoimmuntherapie-bei-nicht-plattenepithelialem-nsclc/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/catalym-doses-first-patient-in-phase-2b-trial-evaluating-visugromab-in-combination-with-chemoimmunotherapy-in-non-squamous-nsclc-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/catalym-behandelt-ersten-patienten-in-phase-2b-studie-zur-bewertung-von-visugromab-in-kombination-mit-chemoimmuntherapie-bei-nicht-plattenepithelialem-nsclc/" />
		<lastmod>2026-07-22T08:18:58+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/iStock-2175821635_MTStock-Studio_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/ibidi-receives-bavarias-best-50-state-award-for-strong-growth/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/ibidi-mit-staatspreis-bayerns-best-50-ausgezeichnet/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/ibidi-receives-bavarias-best-50-state-award-for-strong-growth/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/ibidi-mit-staatspreis-bayerns-best-50-ausgezeichnet/" />
		<lastmod>2026-07-22T08:21:58+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/251008_ibidi_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/tubulis-sichert-sich-344-millionen-euro-in-series-c-finanzierung-zur-weiterentwicklung-seiner-adc-pipeline/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/tubulis-sichert-sich-344-millionen-euro-in-series-c-finanzierung-zur-weiterentwicklung-seiner-adc-pipeline/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/tubulis-secures-e344m-series-c-to-advance-adc-pipeline/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/tubulis-sichert-sich-344-millionen-euro-in-series-c-finanzierung-zur-weiterentwicklung-seiner-adc-pipeline/" />
		<lastmod>2026-07-22T08:22:27+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/2025-Management-Team-Tubulis_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/ibidi-mit-staatspreis-bayerns-best-50-ausgezeichnet/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/ibidi-mit-staatspreis-bayerns-best-50-ausgezeichnet/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/ibidi-receives-bavarias-best-50-state-award-for-strong-growth/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/ibidi-mit-staatspreis-bayerns-best-50-ausgezeichnet/" />
		<lastmod>2026-07-22T08:22:30+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/251008_ibidi_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/catalym-doses-first-patient-in-phase-2b-trial-evaluating-visugromab-in-combination-with-chemoimmunotherapy-in-non-squamous-nsclc-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/catalym-behandelt-ersten-patienten-in-phase-2b-studie-zur-bewertung-von-visugromab-in-kombination-mit-chemoimmuntherapie-bei-nicht-plattenepithelialem-nsclc/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/catalym-doses-first-patient-in-phase-2b-trial-evaluating-visugromab-in-combination-with-chemoimmunotherapy-in-non-squamous-nsclc-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/catalym-behandelt-ersten-patienten-in-phase-2b-studie-zur-bewertung-von-visugromab-in-kombination-mit-chemoimmuntherapie-bei-nicht-plattenepithelialem-nsclc/" />
		<lastmod>2026-07-22T08:26:19+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/iStock-2175821635_MTStock-Studio_600x383-1-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/tubulis-secures-e344m-series-c-to-advance-adc-pipeline/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/tubulis-sichert-sich-344-millionen-euro-in-series-c-finanzierung-zur-weiterentwicklung-seiner-adc-pipeline/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/tubulis-secures-e344m-series-c-to-advance-adc-pipeline/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/tubulis-sichert-sich-344-millionen-euro-in-series-c-finanzierung-zur-weiterentwicklung-seiner-adc-pipeline/" />
		<lastmod>2026-07-22T08:38:16+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/2025-Management-Team-Tubulis_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/amplifold-sichert-5-mio-euro-fuer-ultrasensitive-dna-origami-lateral-flow-diagnostik/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/amplifold-sichert-5-mio-euro-fuer-ultrasensitive-dna-origami-lateral-flow-diagnostik/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/amplifold-raises-e5m-to-advance-dna-origami-ultrasensitive-lateral-flow-diagnostics/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/amplifold-sichert-5-mio-euro-fuer-ultrasensitive-dna-origami-lateral-flow-diagnostik/" />
		<lastmod>2026-07-22T08:38:27+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Amplifold-Team_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/amplifold-raises-e5m-to-advance-dna-origami-ultrasensitive-lateral-flow-diagnostics/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/amplifold-sichert-5-mio-euro-fuer-ultrasensitive-dna-origami-lateral-flow-diagnostik/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/amplifold-raises-e5m-to-advance-dna-origami-ultrasensitive-lateral-flow-diagnostics/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/amplifold-sichert-5-mio-euro-fuer-ultrasensitive-dna-origami-lateral-flow-diagnostik/" />
		<lastmod>2026-07-22T08:38:58+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Amplifold-Team_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/t-curx-sichert-sich-20-mio-us-dollar-in-series-a-finanzierung-zur-weiterentwicklung-einer-nicht-viralen-car-t-plattform/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/t-curx-sichert-sich-20-mio-us-dollar-in-series-a-finanzierung-zur-weiterentwicklung-einer-nicht-viralen-car-t-plattform/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/t-curx-secures-20m-series-a-to-advance-non-viral-car-t-platform/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/t-curx-sichert-sich-20-mio-us-dollar-in-series-a-finanzierung-zur-weiterentwicklung-einer-nicht-viralen-car-t-plattform/" />
		<lastmod>2026-07-22T08:39:28+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/iStock-882303654_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/t-curx-secures-20m-series-a-to-advance-non-viral-car-t-platform/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/t-curx-sichert-sich-20-mio-us-dollar-in-series-a-finanzierung-zur-weiterentwicklung-einer-nicht-viralen-car-t-plattform/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/t-curx-secures-20m-series-a-to-advance-non-viral-car-t-platform/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/t-curx-sichert-sich-20-mio-us-dollar-in-series-a-finanzierung-zur-weiterentwicklung-einer-nicht-viralen-car-t-plattform/" />
		<lastmod>2026-07-22T08:39:54+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/iStock-882303654_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/twogee-biotech-erhaelt-216-mio-e-seed-finanzierung-fuer-enzymplattform/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/twogee-biotech-erhaelt-216-mio-e-seed-finanzierung-fuer-enzymplattform/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/twogee-biotech-raises-e2-16m-seed-round-for-enzyme-platform/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/twogee-biotech-erhaelt-216-mio-e-seed-finanzierung-fuer-enzymplattform/" />
		<lastmod>2026-07-22T08:45:24+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Twogee_team_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/protevo-bio-uebernimmt-plattformtechnologien-zur-skalierbaren-proteinproduktion/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/protevo-bio-uebernimmt-plattformtechnologien-zur-skalierbaren-proteinproduktion/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/protevo-bio-acquires-platform-technologies-for-scalable-protein-production/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/protevo-bio-uebernimmt-plattformtechnologien-zur-skalierbaren-proteinproduktion/" />
		<lastmod>2026-07-22T08:54:11+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/protevo_-Dr.-Marco-Giuman-und-Dr.-Konstantinos-Antonopoulos_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/protevo-bio-acquires-platform-technologies-for-scalable-protein-production/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/protevo-bio-uebernimmt-plattformtechnologien-zur-skalierbaren-proteinproduktion/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/protevo-bio-acquires-platform-technologies-for-scalable-protein-production/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/protevo-bio-uebernimmt-plattformtechnologien-zur-skalierbaren-proteinproduktion/" />
		<lastmod>2026-07-22T09:42:12+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/protevo_-Dr.-Marco-Giuman-und-Dr.-Konstantinos-Antonopoulos_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/30-jahre-izb-deutschlands-globaler-hotspot-fuer-biotechnologie-ein-gespraech-mit-christian-gnam/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/30-jahre-izb-deutschlands-globaler-hotspot-fuer-biotechnologie-ein-gespraech-mit-christian-gnam/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/30-years-of-izb-inside-germanys-global-biotech-village-with-christian-gnam/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/30-jahre-izb-deutschlands-globaler-hotspot-fuer-biotechnologie-ein-gespraech-mit-christian-gnam/" />
		<lastmod>2026-07-22T09:42:17+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/grundsteinlegung-izb_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/30-years-of-izb-inside-germanys-global-biotech-village-with-christian-gnam/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/30-jahre-izb-deutschlands-globaler-hotspot-fuer-biotechnologie-ein-gespraech-mit-christian-gnam/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/30-years-of-izb-inside-germanys-global-biotech-village-with-christian-gnam/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/30-jahre-izb-deutschlands-globaler-hotspot-fuer-biotechnologie-ein-gespraech-mit-christian-gnam/" />
		<lastmod>2026-07-22T09:42:22+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/grundsteinlegung-izb_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/aatec-medical-erhaelt-4-millionen-euro-fuer-klinische-studien-zu-atemwegstherapien/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/aatec-medical-erhaelt-4-millionen-euro-fuer-klinische-studien-zu-atemwegstherapien/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/aatec-medical-raises-eur-4-million-for-respiratory-drug-trials/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/aatec-medical-erhaelt-4-millionen-euro-fuer-klinische-studien-zu-atemwegstherapien/" />
		<lastmod>2026-07-22T09:42:27+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/250415_Aatec-Medical-Funding_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/aatec-medical-raises-eur-4-million-for-respiratory-drug-trials/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/aatec-medical-erhaelt-4-millionen-euro-fuer-klinische-studien-zu-atemwegstherapien/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/aatec-medical-raises-eur-4-million-for-respiratory-drug-trials/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/aatec-medical-erhaelt-4-millionen-euro-fuer-klinische-studien-zu-atemwegstherapien/" />
		<lastmod>2026-07-22T09:42:31+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/250415_Aatec-Medical-Funding_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/gilead-and-tubulis-enter-into-exclusive-option-and-license-agreement/</loc>
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/gilead-and-tubulis-enter-into-exclusive-option-and-license-agreement/" />
		<lastmod>2026-07-22T10:20:47+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/2412_Tubulis-Gilead_2000x1098.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/catalyms-visugromab-breakthrough-in-reversing-cancer-resistance-published-in-nature/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/catalyms-visugromab-durchbruch-bei-aufhebung-von-checkpoint-inhibitor-resistenz-in-nature-veroeffentlicht/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/catalyms-visugromab-breakthrough-in-reversing-cancer-resistance-published-in-nature/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/catalyms-visugromab-durchbruch-bei-aufhebung-von-checkpoint-inhibitor-resistenz-in-nature-veroeffentlicht/" />
		<lastmod>2026-07-22T10:20:55+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/iStock_Bildnachweis-Halfpoint_1929440388_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/catalyms-visugromab-durchbruch-bei-aufhebung-von-checkpoint-inhibitor-resistenz-in-nature-veroeffentlicht/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/catalyms-visugromab-durchbruch-bei-aufhebung-von-checkpoint-inhibitor-resistenz-in-nature-veroeffentlicht/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/catalyms-visugromab-breakthrough-in-reversing-cancer-resistance-published-in-nature/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/catalyms-visugromab-durchbruch-bei-aufhebung-von-checkpoint-inhibitor-resistenz-in-nature-veroeffentlicht/" />
		<lastmod>2026-07-22T10:21:03+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/iStock_Bildnachweis-Halfpoint_1929440388_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/tubulis-sichert-sich-bedeutende-serie-b2-finanzierung-in-hoehe-von-128-mio-euro-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/tubulis-sichert-sich-bedeutende-serie-b2-finanzierung-in-hoehe-von-128-mio-euro-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/tubulis-secures-significant-eur-128-million-series-b2-financing-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/tubulis-sichert-sich-bedeutende-serie-b2-finanzierung-in-hoehe-von-128-mio-euro-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-22T10:21:08+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/iStock-1484472027_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/immunic-praesentierte-in-einem-fe-webcast-zu-multipler-sklerose-neue-daten-zu-ihrem-hauptprodukt-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/immunic-praesentierte-in-einem-fe-webcast-zu-multipler-sklerose-neue-daten-zu-ihrem-hauptprodukt-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-22T11:27:19+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Immunic_Team.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/crashkurs-biotechnologie-wissen-fuer-nicht-biologen/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/crashkurs-biotechnologie-wissen-fuer-nicht-biologen/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/crashkurs-biotechnologie-wissen-fuer-nicht-biologen/" />
		<lastmod>2026-07-22T11:28:08+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Kurs-BioM_iStock-962182556_2000x1098.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/morphosys-beendet-das-jahr-mit-positiven-phase-3-daten-und-erfolgreicher-barkapitalerhoehung-von-rund-1027-millionen-euro-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/morphosys-beendet-das-jahr-mit-positiven-phase-3-daten-und-erfolgreicher-barkapitalerhoehung-von-rund-1027-millionen-euro-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/morphosys-ends-the-year-with-positive-phase-3-data-and-successful-cash-capital-increase-of-approximately-eur-102-7-million-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/morphosys-beendet-das-jahr-mit-positiven-phase-3-daten-und-erfolgreicher-barkapitalerhoehung-von-rund-1027-millionen-euro-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-22T11:28:25+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/morphosys_1a_morphosys-gebaeude_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/morphosys-ends-the-year-with-positive-phase-3-data-and-successful-cash-capital-increase-of-approximately-eur-102-7-million-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/morphosys-beendet-das-jahr-mit-positiven-phase-3-daten-und-erfolgreicher-barkapitalerhoehung-von-rund-1027-millionen-euro-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/morphosys-ends-the-year-with-positive-phase-3-data-and-successful-cash-capital-increase-of-approximately-eur-102-7-million-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/morphosys-beendet-das-jahr-mit-positiven-phase-3-daten-und-erfolgreicher-barkapitalerhoehung-von-rund-1027-millionen-euro-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-22T11:28:30+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/morphosys_1a_morphosys-gebaeude_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/praeklinische-wirksamkeits-und-sicherheitsdaten-fuer-vigenerons-innovativen-ansatz-zur-behandlung-von-retinitis-pigmentosa-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/praeklinische-wirksamkeits-und-sicherheitsdaten-fuer-vigenerons-innovativen-ansatz-zur-behandlung-von-retinitis-pigmentosa-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/preclinical-efficacy-and-safety-data-for-vigenerons-innovative-approach-to-the-treatment-of-retinitis-pigmentosa-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/praeklinische-wirksamkeits-und-sicherheitsdaten-fuer-vigenerons-innovativen-ansatz-zur-behandlung-von-retinitis-pigmentosa-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-22T12:06:56+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/ViGeneron_Retinitis_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/new-high-tech-approach-to-detect-diseased-cells-at-an-early-stage-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/izb-biotech-news-neuer-hightech-ansatz-zur-fruehzeitigen-erkennung-kranker-zellen-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/new-high-tech-approach-to-detect-diseased-cells-at-an-early-stage-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/izb-biotech-news-neuer-hightech-ansatz-zur-fruehzeitigen-erkennung-kranker-zellen-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-22T12:18:11+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Helmholtz-Zentrum_neuer-Ansatz_Bild1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/business-reception-2023-innovation-and-founder-center-biotechnology-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/wirtschaftsempfang-2023-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/business-reception-2023-innovation-and-founder-center-biotechnology-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/wirtschaftsempfang-2023-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-22T12:51:00+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Header-Wirtschaftsempfang_Text_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/christian-gnam-folgt-dr-peter-zobel-und-wird-neuer-geschaeftsfuehrer-des-innovations-und-gruenderzentrums-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/christian-gnam-folgt-dr-peter-zobel-und-wird-neuer-geschaeftsfuehrer-des-innovations-und-gruenderzentrums-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/christian-gnam-succeeds-dr-peter-zobel-as-new-managing-director-of-the-biotechnology-innovation-and-start-up-center-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/christian-gnam-folgt-dr-peter-zobel-und-wird-neuer-geschaeftsfuehrer-des-innovations-und-gruenderzentrums-biotechnologie-izb/" />
		<lastmod>2026-07-22T12:54:01+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Christian-Gnam_2000x1098.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/christian-gnam-succeeds-dr-peter-zobel-as-new-managing-director-of-the-biotechnology-innovation-and-start-up-center-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/christian-gnam-folgt-dr-peter-zobel-und-wird-neuer-geschaeftsfuehrer-des-innovations-und-gruenderzentrums-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/christian-gnam-succeeds-dr-peter-zobel-as-new-managing-director-of-the-biotechnology-innovation-and-start-up-center-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/christian-gnam-folgt-dr-peter-zobel-und-wird-neuer-geschaeftsfuehrer-des-innovations-und-gruenderzentrums-biotechnologie-izb/" />
		<lastmod>2026-07-22T12:54:09+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Christian-Gnam_2000x1098.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/tubulis-secures-significant-eur-128-million-series-b2-financing-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/tubulis-sichert-sich-bedeutende-serie-b2-finanzierung-in-hoehe-von-128-mio-euro-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/tubulis-secures-significant-eur-128-million-series-b2-financing-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/tubulis-sichert-sich-bedeutende-serie-b2-finanzierung-in-hoehe-von-128-mio-euro-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-22T12:55:04+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/iStock-1484472027_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/preclinical-efficacy-and-safety-data-for-vigenerons-innovative-approach-to-the-treatment-of-retinitis-pigmentosa-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/praeklinische-wirksamkeits-und-sicherheitsdaten-fuer-vigenerons-innovativen-ansatz-zur-behandlung-von-retinitis-pigmentosa-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/preclinical-efficacy-and-safety-data-for-vigenerons-innovative-approach-to-the-treatment-of-retinitis-pigmentosa-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/praeklinische-wirksamkeits-und-sicherheitsdaten-fuer-vigenerons-innovativen-ansatz-zur-behandlung-von-retinitis-pigmentosa-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-22T12:56:55+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/ViGeneron_Retinitis_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/an-evening-for-new-connections-business-reception-at-the-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/ein-abend-fuer-neue-netzwerke-wirtschaftsempfang-2025-im-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/an-evening-for-new-connections-business-reception-at-the-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/ein-abend-fuer-neue-netzwerke-wirtschaftsempfang-2025-im-izb/" />
		<lastmod>2026-07-22T14:07:26+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Wirtschaftsempfang-3-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/25699/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/image-video-izb-2025/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/25699/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/image-video-izb-2025/" />
		<lastmod>2026-07-22T14:28:15+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Image-Video-Thumb2.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/zwei-auszeichnungen-fuer-max-planck-forscher-elena-conti-und-wolfgang-baumeister/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/zwei-auszeichnungen-fuer-max-planck-forscher-elena-conti-und-wolfgang-baumeister/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/max-planck-scientists-elena-conti-and-wolfgang-baumeister-receive-prestigious-awards/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/zwei-auszeichnungen-fuer-max-planck-forscher-elena-conti-und-wolfgang-baumeister/" />
		<lastmod>2026-07-22T14:40:45+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Baumeister_Conti_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/max-planck-scientists-elena-conti-and-wolfgang-baumeister-receive-prestigious-awards/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/zwei-auszeichnungen-fuer-max-planck-forscher-elena-conti-und-wolfgang-baumeister/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/max-planck-scientists-elena-conti-and-wolfgang-baumeister-receive-prestigious-awards/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/zwei-auszeichnungen-fuer-max-planck-forscher-elena-conti-und-wolfgang-baumeister/" />
		<lastmod>2026-07-22T14:40:52+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Baumeister_Conti_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/drei-izb-start-ups-gewinnen-european-lifestars-awards-2024-in-london/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/drei-izb-start-ups-gewinnen-european-lifestars-awards-2024-in-london/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/three-izb-start-ups-win-european-lifestars-award-2024-in-london/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/drei-izb-start-ups-gewinnen-european-lifestars-awards-2024-in-london/" />
		<lastmod>2026-07-22T14:58:54+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/IZB-Startups-bei-deh-Lifestars-Awards_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/three-izb-start-ups-win-european-lifestars-award-2024-in-london/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/drei-izb-start-ups-gewinnen-european-lifestars-awards-2024-in-london/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/three-izb-start-ups-win-european-lifestars-award-2024-in-london/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/drei-izb-start-ups-gewinnen-european-lifestars-awards-2024-in-london/" />
		<lastmod>2026-07-22T14:59:03+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/IZB-Startups-bei-deh-Lifestars-Awards_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/30-jahre-izb-jubilaeum-eines-biotech-pioniers-izb-martinsried/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/30-jahre-izb-jubilaeum-eines-biotech-pioniers-izb-martinsried/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/30-years-izb-anniversary-of-a-biotech-pioneer-izb-martinsried/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/30-jahre-izb-jubilaeum-eines-biotech-pioniers-izb-martinsried/" />
		<lastmod>2026-07-22T15:11:18+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/250604_30-Jahre-IZB_2000px.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/30-years-izb-anniversary-of-a-biotech-pioneer-izb-martinsried/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/30-jahre-izb-jubilaeum-eines-biotech-pioniers-izb-martinsried/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/30-years-izb-anniversary-of-a-biotech-pioneer-izb-martinsried/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/30-jahre-izb-jubilaeum-eines-biotech-pioniers-izb-martinsried/" />
		<lastmod>2026-07-22T15:12:53+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/250604_30-Jahre-IZB_2000px-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/grosse-buehne-dpa-berichtet-ueber-izb-strat-ups/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/grosse-buehne-dpa-berichtet-ueber-izb-strat-ups/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/in-the-spotlight-dpa-features-izb-start-ups/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/grosse-buehne-dpa-berichtet-ueber-izb-strat-ups/" />
		<lastmod>2026-07-22T15:13:31+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/tz_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/in-the-spotlight-dpa-features-izb-start-ups/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/grosse-buehne-dpa-berichtet-ueber-izb-strat-ups/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/in-the-spotlight-dpa-features-izb-start-ups/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/grosse-buehne-dpa-berichtet-ueber-izb-strat-ups/" />
		<lastmod>2026-07-22T15:14:09+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/tz_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/durchbruch-in-der-fluoreszenzmikroskopie-am-max-planck-institut-fuer-biochemie-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/durchbruch-in-der-fluoreszenzmikroskopie-am-max-planck-institut-fuer-biochemie-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/breakthrough-in-fluorescence-microscopy-at-the-max-planck-institute-of-biochemistry-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/durchbruch-in-der-fluoreszenzmikroskopie-am-max-planck-institut-fuer-biochemie-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T10:10:26+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/multiskalige-Mikroskopie-mit-Angstroem-Aufloesung_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/breakthrough-in-fluorescence-microscopy-at-the-max-planck-institute-of-biochemistry-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/durchbruch-in-der-fluoreszenzmikroskopie-am-max-planck-institut-fuer-biochemie-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/breakthrough-in-fluorescence-microscopy-at-the-max-planck-institute-of-biochemistry-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/durchbruch-in-der-fluoreszenzmikroskopie-am-max-planck-institut-fuer-biochemie-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T10:10:38+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/multiskalige-Mikroskopie-mit-Angstroem-Aufloesung_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/max-planck-institut-fuer-biochemie-veroeffentlichung-in-nature-ueber-die-dunkle-materie-der-proteomik-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/max-planck-institut-fuer-biochemie-veroeffentlichung-in-nature-ueber-die-dunkle-materie-der-proteomik-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/max-planck-institute-of-biochemistry-nature-publication-addressing-the-dark-matter-of-proteomics-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/max-planck-institut-fuer-biochemie-veroeffentlichung-in-nature-ueber-die-dunkle-materie-der-proteomik-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T10:10:59+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/AdobeStock-bearbeitet_MPI_Advanced-Deep-Proteomics_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/max-planck-institute-of-biochemistry-nature-publication-addressing-the-dark-matter-of-proteomics-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/max-planck-institut-fuer-biochemie-veroeffentlichung-in-nature-ueber-die-dunkle-materie-der-proteomik-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/max-planck-institute-of-biochemistry-nature-publication-addressing-the-dark-matter-of-proteomics-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/max-planck-institut-fuer-biochemie-veroeffentlichung-in-nature-ueber-die-dunkle-materie-der-proteomik-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T10:11:37+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/AdobeStock-bearbeitet_MPI_Advanced-Deep-Proteomics_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/goingpublic-celebrates-a-quarter-century-of-biotech-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/goingpublic-feiert-ein-vierteljahrhundert-biotech-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/goingpublic-celebrates-a-quarter-century-of-biotech-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/goingpublic-feiert-ein-vierteljahrhundert-biotech-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T12:20:14+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/1_MAR8027_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/zurueck-mit-spannenden-themen-und-multimedialer-zaubershow-der-jahresempfang-des-lmu-klinikums-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/zurueck-mit-spannenden-themen-und-multimedialer-zaubershow-der-jahresempfang-des-lmu-klinikums-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/lmu-hospitals-annual-reception-returned-this-year-with-exciting-topics-and-a-multimedia-magic-show-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/zurueck-mit-spannenden-themen-und-multimedialer-zaubershow-der-jahresempfang-des-lmu-klinikums-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T12:45:00+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Podiumsdiskussion-Jahresempfang-2023_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/lmu-hospitals-annual-reception-returned-this-year-with-exciting-topics-and-a-multimedia-magic-show-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/zurueck-mit-spannenden-themen-und-multimedialer-zaubershow-der-jahresempfang-des-lmu-klinikums-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/lmu-hospitals-annual-reception-returned-this-year-with-exciting-topics-and-a-multimedia-magic-show-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/zurueck-mit-spannenden-themen-und-multimedialer-zaubershow-der-jahresempfang-des-lmu-klinikums-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T12:45:17+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Podiumsdiskussion-Jahresempfang-2023_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/das-izb-zieht-globale-biotech-partner-an/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/das-izb-zieht-globale-biotech-partner-an/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/izb-attracts-global-biotech-partners/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/das-izb-zieht-globale-biotech-partner-an/" />
		<lastmod>2026-07-23T12:57:59+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/us-gruppe_bearbeitet_2000x1098.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/izb-attracts-global-biotech-partners/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/das-izb-zieht-globale-biotech-partner-an/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/izb-attracts-global-biotech-partners/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/das-izb-zieht-globale-biotech-partner-an/" />
		<lastmod>2026-07-23T12:58:13+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/us-gruppe_bearbeitet_2000x1098.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/t-curx-staerkt-in-vivo-car-t-plattform-durch-uebernahme-von-pantherna-therapeutics-und-erhaelt-phase-1-zulassung-fuer-tcx-001/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/t-curx-staerkt-in-vivo-car-t-plattform-durch-uebernahme-von-pantherna-therapeutics-und-erhaelt-phase-1-zulassung-fuer-tcx-001/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/t-curx-strengthens-in-vivo-car-t-platform-with-pantherna-acquisition-and-achieves-phase-1-approval-for-tcx-001/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/t-curx-staerkt-in-vivo-car-t-plattform-durch-uebernahme-von-pantherna-therapeutics-und-erhaelt-phase-1-zulassung-fuer-tcx-001/" />
		<lastmod>2026-07-23T14:48:15+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Nemes-Laszlo_iStock-2175600990_2000x1098.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/biom-laedt-zur-bayoconnect-forum-for-biotech-lifescience/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/biom-laedt-zur-bayoconnect-forum-for-biotech-lifescience/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/biom-invites-to-bayoconnect-forum-for-biotech-lifescience/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/biom-laedt-zur-bayoconnect-forum-for-biotech-lifescience/" />
		<lastmod>2026-07-23T16:23:06+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/08/BayOConnect_Social-Meida_1200x627px_3.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/tag-der-offenen-tuer-am-biomedizinischen-centrum-der-lmu-am-16-maerz/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/tag-der-offenen-tuer-am-biomedizinischen-centrum-der-lmu-am-16-maerz/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/open-day-at-the-lmu-biomedical-center-on-march-16/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/tag-der-offenen-tuer-am-biomedizinischen-centrum-der-lmu-am-16-maerz/" />
		<lastmod>2026-07-23T16:23:12+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/08/BMC-TdOT-2024_600x383_4.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/peutinger-collegium-besucht-das-izb-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/peutinger-collegium-besucht-das-izb-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/peutinger-collegium-visits-the-izb-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/peutinger-collegium-besucht-das-izb-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T16:23:20+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/DZ6_5959_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/vivoryon-therapeutics-verkuendet-fortschritte-des-lead-kandidaten-varoglutamstat-zur-behandlung-von-alzheimer-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/vivoryon-therapeutics-verkuendet-fortschritte-des-lead-kandidaten-varoglutamstat-zur-behandlung-von-alzheimer-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/vivoryon-therapeutics-highlights-progress-of-lead-candidate-varoglutamstat-in-alzheimers-disease-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/vivoryon-therapeutics-verkuendet-fortschritte-des-lead-kandidaten-varoglutamstat-zur-behandlung-von-alzheimer-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T16:23:29+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Dr.-Ulrich-Dauer_Vivoryon_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/bayerische-biotechnologie-behauptet-sich-in-der-krise-und-waechst-weiter-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/bayerische-biotechnologie-behauptet-sich-in-der-krise-und-waechst-weiter-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/bavarian-biotechnology-maintains-its-position-in-the-crisis-and-continues-to-grow-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/bayerische-biotechnologie-behauptet-sich-in-der-krise-und-waechst-weiter-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T16:23:31+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/biotech-report-titelseite-2023-06_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/leon-nanodrugs-begruesst-dr-hans-frickel-als-neuen-ceo-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/leon-nanodrugs-begruesst-dr-hans-frickel-als-neuen-ceo-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/leon-nanodrugs-welcomes-dr-hans-frickel-as-new-chief-executive-officer-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/leon-nanodrugs-begruesst-dr-hans-frickel-als-neuen-ceo-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T16:23:35+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/20230719_Hans-Frickel_CEO_leon-nanodrugs_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/japanische-delegation-besucht-das-izb-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/japanische-delegation-besucht-das-izb-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/japanese-delegation-visits-the-izb-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/japanische-delegation-besucht-das-izb-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T16:23:37+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/MAR1984_1000x667.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/klifo-bringt-den-midsommar-ins-izb-izb-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/klifo-bringt-den-midsommar-ins-izb-izb-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/klifo-brings-midsommar-to-the-izb-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/klifo-bringt-den-midsommar-ins-izb-izb-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T16:23:41+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/170713_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/bicoll-praesentiert-auf-der-bio-international-convention/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/bicoll-praesentiert-auf-der-bio-international-convention/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/bicoll-showcases-at-bio-international-convention/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/bicoll-praesentiert-auf-der-bio-international-convention/" />
		<lastmod>2026-07-23T16:23:46+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Bicoll_auf-der-BIO-BIO-International-Convention-Juni-2023_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/offizielle-amtsuebergabe-auf-der-jahrestagung-der-max-planck-gesellschaft-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/offizielle-amtsuebergabe-auf-der-jahrestagung-der-max-planck-gesellschaft-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/official-handoff-ceremony-at-the-annual-meeting-of-the-max-planck-society-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/offizielle-amtsuebergabe-auf-der-jahrestagung-der-max-planck-gesellschaft-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T16:23:52+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/MPG_Amtsuebergabe_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/secarna-ernennt-neuen-chief-business-officer-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/secarna-ernennt-neuen-chief-business-officer-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/secarna-appoints-new-chief-business-officer-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/secarna-ernennt-neuen-chief-business-officer-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T16:23:55+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Konstantin-Petropoulos_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/biotech-firma-origenis-begruesst-prof-hendrik-liebers-als-chairman-of-the-board-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/biotech-firma-origenis-begruesst-prof-hendrik-liebers-als-chairman-of-the-board-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/biotech-company-origenis-welcomes-prof-hendrik-liebers-as-chairman-of-the-board/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/biotech-firma-origenis-begruesst-prof-hendrik-liebers-als-chairman-of-the-board-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T16:23:57+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Prof.-Hendrik-Liebers_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/thermosome-tritt-dem-imagio-konsortium-bei-um-die-entwicklung-von-krebstherapien-fuer-weichteilsarkome-voranzutreiben-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/thermosome-tritt-dem-imagio-konsortium-bei-um-die-entwicklung-von-krebstherapien-fuer-weichteilsarkome-voranzutreiben-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/thermosome-joins-imagio-consortium-to-advance-development-of-cancer-therapies-for-soft-tissue-sarcoma-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/thermosome-tritt-dem-imagio-konsortium-bei-um-die-entwicklung-von-krebstherapien-fuer-weichteilsarkome-voranzutreiben-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T16:24:00+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Thermosensitive-Liposomen-die-mit-Wirkstoffen-beladen-sind_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/ausbau-der-muenchner-wissenschaftslinie-hat-begonnen/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/ausbau-der-muenchner-wissenschaftslinie-hat-begonnen/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/expansion-of-the-munich-science-line-has-started-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/ausbau-der-muenchner-wissenschaftslinie-hat-begonnen/" />
		<lastmod>2026-07-23T16:24:02+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/10/01_Spatenstich-Headerbild-02.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/9-munich-life-science-pitch-day-at-the-izb-innovations-meet-investors/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/9th-munich-life-science-pitch-day-im-izb-innovationen-treffen-investoren/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/9-munich-life-science-pitch-day-at-the-izb-innovations-meet-investors/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/9th-munich-life-science-pitch-day-im-izb-innovationen-treffen-investoren/" />
		<lastmod>2026-07-23T16:24:15+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/10/pitch-day-24_Networking_1032x687.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/expansion-of-the-munich-science-line-has-started-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/ausbau-der-muenchner-wissenschaftslinie-hat-begonnen/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/expansion-of-the-munich-science-line-has-started-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/ausbau-der-muenchner-wissenschaftslinie-hat-begonnen/" />
		<lastmod>2026-07-23T16:24:17+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/10/01_Spatenstich-Headerbild-02.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/bavarian-biotechnology-maintains-its-position-in-the-crisis-and-continues-to-grow-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/bayerische-biotechnologie-behauptet-sich-in-der-krise-und-waechst-weiter-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/bavarian-biotechnology-maintains-its-position-in-the-crisis-and-continues-to-grow-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/bayerische-biotechnologie-behauptet-sich-in-der-krise-und-waechst-weiter-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T16:24:19+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/biotech-report-titelseite-2023-06_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/bicoll-showcases-at-bio-international-convention/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/bicoll-praesentiert-auf-der-bio-international-convention/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/bicoll-showcases-at-bio-international-convention/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/bicoll-praesentiert-auf-der-bio-international-convention/" />
		<lastmod>2026-07-23T16:24:21+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Bicoll_auf-der-BIO-BIO-International-Convention-Juni-2023_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/biom-invites-to-bayoconnect-forum-for-biotech-lifescience/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/biom-laedt-zur-bayoconnect-forum-for-biotech-lifescience/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/biom-invites-to-bayoconnect-forum-for-biotech-lifescience/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/biom-laedt-zur-bayoconnect-forum-for-biotech-lifescience/" />
		<lastmod>2026-07-23T16:24:24+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/08/BayOConnect_Social-Meida_1200x627px_3.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/biotech-company-origenis-welcomes-prof-hendrik-liebers-as-chairman-of-the-board/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/biotech-firma-origenis-begruesst-prof-hendrik-liebers-als-chairman-of-the-board-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/biotech-company-origenis-welcomes-prof-hendrik-liebers-as-chairman-of-the-board/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/biotech-firma-origenis-begruesst-prof-hendrik-liebers-als-chairman-of-the-board-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T16:24:27+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Prof.-Hendrik-Liebers_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/peutinger-collegium-visits-the-izb-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/peutinger-collegium-besucht-das-izb-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/peutinger-collegium-visits-the-izb-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/peutinger-collegium-besucht-das-izb-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T16:24:30+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/DZ6_5959_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/the-munich-bavaria-student-union-visits-the-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/das-studierendenwerk-muenchen-oberbayern-besucht-das-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/the-munich-bavaria-student-union-visits-the-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/das-studierendenwerk-muenchen-oberbayern-besucht-das-izb/" />
		<lastmod>2026-07-23T16:24:33+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Studierendenwerk_MAR9408_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/japanese-delegation-visits-the-izb-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/japanische-delegation-besucht-das-izb-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/japanese-delegation-visits-the-izb-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/japanische-delegation-besucht-das-izb-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T16:24:35+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/MAR1984_1000x667.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/klifo-brings-midsommar-to-the-izb-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/klifo-bringt-den-midsommar-ins-izb-izb-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/klifo-brings-midsommar-to-the-izb-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/klifo-bringt-den-midsommar-ins-izb-izb-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T16:24:41+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/170713_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/leon-nanodrugs-welcomes-dr-hans-frickel-as-new-chief-executive-officer-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/leon-nanodrugs-begruesst-dr-hans-frickel-als-neuen-ceo-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/leon-nanodrugs-welcomes-dr-hans-frickel-as-new-chief-executive-officer-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/leon-nanodrugs-begruesst-dr-hans-frickel-als-neuen-ceo-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T16:24:45+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/20230719_Hans-Frickel_CEO_leon-nanodrugs_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/official-handoff-ceremony-at-the-annual-meeting-of-the-max-planck-society-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/offizielle-amtsuebergabe-auf-der-jahrestagung-der-max-planck-gesellschaft-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/official-handoff-ceremony-at-the-annual-meeting-of-the-max-planck-society-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/offizielle-amtsuebergabe-auf-der-jahrestagung-der-max-planck-gesellschaft-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T16:24:53+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/MPG_Amtsuebergabe_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/oncology-experts-to-support-the-development-of-thermosomes-clinical-candidate-the001-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/onkologie-experten-unterstuetzen-die-entwicklung-des-wirkstoffkandidaten-the001-von-thermosome-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/oncology-experts-to-support-the-development-of-thermosomes-clinical-candidate-the001-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/onkologie-experten-unterstuetzen-die-entwicklung-des-wirkstoffkandidaten-the001-von-thermosome-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T16:24:55+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Gronchi_Hermann_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/secarna-appoints-new-chief-business-officer-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/secarna-ernennt-neuen-chief-business-officer-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/secarna-appoints-new-chief-business-officer-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/secarna-ernennt-neuen-chief-business-officer-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T16:25:04+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Konstantin-Petropoulos_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/open-day-at-the-lmu-biomedical-center-on-march-16/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/tag-der-offenen-tuer-am-biomedizinischen-centrum-der-lmu-am-16-maerz/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/open-day-at-the-lmu-biomedical-center-on-march-16/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/tag-der-offenen-tuer-am-biomedizinischen-centrum-der-lmu-am-16-maerz/" />
		<lastmod>2026-07-23T16:25:08+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/08/BMC-TdOT-2024_600x383_4.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/thermosome-joins-imagio-consortium-to-advance-development-of-cancer-therapies-for-soft-tissue-sarcoma-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/thermosome-tritt-dem-imagio-konsortium-bei-um-die-entwicklung-von-krebstherapien-fuer-weichteilsarkome-voranzutreiben-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/thermosome-joins-imagio-consortium-to-advance-development-of-cancer-therapies-for-soft-tissue-sarcoma-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/thermosome-tritt-dem-imagio-konsortium-bei-um-die-entwicklung-von-krebstherapien-fuer-weichteilsarkome-voranzutreiben-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T16:25:10+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Thermosensitive-Liposomen-die-mit-Wirkstoffen-beladen-sind_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/vivoryon-therapeutics-highlights-progress-of-lead-candidate-varoglutamstat-in-alzheimers-disease-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/vivoryon-therapeutics-verkuendet-fortschritte-des-lead-kandidaten-varoglutamstat-zur-behandlung-von-alzheimer-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/vivoryon-therapeutics-highlights-progress-of-lead-candidate-varoglutamstat-in-alzheimers-disease-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/vivoryon-therapeutics-verkuendet-fortschritte-des-lead-kandidaten-varoglutamstat-zur-behandlung-von-alzheimer-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-07-23T16:25:13+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/Dr.-Ulrich-Dauer_Vivoryon_2000x1098.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/pipeline-in-a-molecule-ein-innovativer-ansatz-mit-breitbandeffekt/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/pipeline-in-a-molecule-ein-innovativer-ansatz-mit-breitbandeffekt/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/pipeline-in-a-molecule-an-innovative-application-with-a-broad-spectrum-effect/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/pipeline-in-a-molecule-ein-innovativer-ansatz-mit-breitbandeffekt/" />
		<lastmod>2026-07-23T16:28:20+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/08/atriva_iStock-973050760_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/pipeline-in-a-molecule-an-innovative-application-with-a-broad-spectrum-effect/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/pipeline-in-a-molecule-ein-innovativer-ansatz-mit-breitbandeffekt/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/pipeline-in-a-molecule-an-innovative-application-with-a-broad-spectrum-effect/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/pipeline-in-a-molecule-ein-innovativer-ansatz-mit-breitbandeffekt/" />
		<lastmod>2026-07-23T16:28:23+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/08/atriva_iStock-973050760_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/neue-niedermolekulare-medikamente-der-zukunft-fuer-das-zns/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/neue-niedermolekulare-medikamente-der-zukunft-fuer-das-zns/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/novel-small-molecule-drugs-of-the-future-targeting-the-cns/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/neue-niedermolekulare-medikamente-der-zukunft-fuer-das-zns/" />
		<lastmod>2026-07-23T16:28:25+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/08/Reagenzglaeser-und-Pipette-im-Labor_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/novel-small-molecule-drugs-of-the-future-targeting-the-cns/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/neue-niedermolekulare-medikamente-der-zukunft-fuer-das-zns/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/novel-small-molecule-drugs-of-the-future-targeting-the-cns/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/neue-niedermolekulare-medikamente-der-zukunft-fuer-das-zns/" />
		<lastmod>2026-07-23T16:28:33+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/08/Reagenzglaeser-und-Pipette-im-Labor_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/ein-nukleinsaeurechemie-cluster-soll-deutschlands-fe-zukunft-gestalten/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/ein-nukleinsaeurechemie-cluster-soll-deutschlands-fe-zukunft-gestalten/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/a-nucleic-acid-chemistry-cluster-to-shape-germanys-rd-future/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/ein-nukleinsaeurechemie-cluster-soll-deutschlands-fe-zukunft-gestalten/" />
		<lastmod>2026-07-29T14:58:33+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/eisbach-bio-izb-biotech-news.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/a-nucleic-acid-chemistry-cluster-to-shape-germanys-rd-future/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/ein-nukleinsaeurechemie-cluster-soll-deutschlands-fe-zukunft-gestalten/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/a-nucleic-acid-chemistry-cluster-to-shape-germanys-rd-future/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/ein-nukleinsaeurechemie-cluster-soll-deutschlands-fe-zukunft-gestalten/" />
		<lastmod>2026-07-29T15:00:04+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/eisbach-bio-izb-biotech-news.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/thermosome-reports-positive-phase-i-results-for-the001-in-advanced-soft-tissue-sarcomas/</loc>
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/thermosome-reports-positive-phase-i-results-for-the001-in-advanced-soft-tissue-sarcomas/" />
		<lastmod>2026-07-29T15:01:11+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Thermosome-Studienergebnisse_2000x1098.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/thermosome-initiates-final-dose-level-in-phase-i-trial/</loc>
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/thermosome-initiates-final-dose-level-in-phase-i-trial/" />
		<lastmod>2026-07-29T15:03:37+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/iStock_Bildnachweis-sanjeri_931689108_2000x1098.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/twogee-biotech-mit-enzymen-biomasseabfaelle-in-nachhaltige-2g-rohstoffe-verwandeln/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/twogee-biotech-mit-enzymen-biomasseabfaelle-in-nachhaltige-2g-rohstoffe-verwandeln/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/twogee-biotech-turning-biomass-waste-into-sustainable-2g-raw-materials-with-enzymes/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/twogee-biotech-mit-enzymen-biomasseabfaelle-in-nachhaltige-2g-rohstoffe-verwandeln/" />
		<lastmod>2026-07-30T18:52:04+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/iStock-1342977868_600x383_erweitert-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/twogee-biotech-turning-biomass-waste-into-sustainable-2g-raw-materials-with-enzymes/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/twogee-biotech-mit-enzymen-biomasseabfaelle-in-nachhaltige-2g-rohstoffe-verwandeln/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/twogee-biotech-turning-biomass-waste-into-sustainable-2g-raw-materials-with-enzymes/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/twogee-biotech-mit-enzymen-biomasseabfaelle-in-nachhaltige-2g-rohstoffe-verwandeln/" />
		<lastmod>2026-07-30T18:52:27+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/iStock-1342977868_600x383_erweitert-1-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/23-studenten-aus-europa-besuchten-im-rahmen-des-amgen-scholar-program-das-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/23-studenten-aus-europa-besuchten-im-rahmen-des-amgen-scholar-program-das-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/23-students-from-europe-visited-the-izb-as-part-of-the-amgen-scholar-program/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/23-studenten-aus-europa-besuchten-im-rahmen-des-amgen-scholar-program-das-izb/" />
		<lastmod>2026-08-12T12:49:16+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2024/09/DZ6_0307-2000x1098-1.webp</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/bau-des-neuen-hauner-am-campus-grosshadern-hat-begonnen-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/bau-des-neuen-hauner-am-campus-grosshadern-hat-begonnen-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/construction-of-the-new-hauner-at-the-grosshadern-campus-has-started-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/bau-des-neuen-hauner-am-campus-grosshadern-hat-begonnen-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-08-12T13:07:14+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Spatenstich-Kinderklinik_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/construction-of-the-new-hauner-at-the-grosshadern-campus-has-started-innovations-und-gruenderzentrum-biotechnologie-izb/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/bau-des-neuen-hauner-am-campus-grosshadern-hat-begonnen-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/construction-of-the-new-hauner-at-the-grosshadern-campus-has-started-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/bau-des-neuen-hauner-am-campus-grosshadern-hat-begonnen-innovations-und-gruenderzentrum-biotechnologie-izb/" />
		<lastmod>2026-08-12T13:13:51+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Spatenstich-Kinderklinik_600x383-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/amsilk-zieht-vom-izb-in-groessere-raeumlichkeiten-um-und-plant-den-ausbau-der-produktion-von-nachhaltigen-materialloesungen/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/amsilk-zieht-vom-izb-in-groessere-raeumlichkeiten-um-und-plant-den-ausbau-der-produktion-von-nachhaltigen-materialloesungen/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/amsilk-relocates-from-izb-to-larger-premises-with-plans-to-scale-up-its-production-of-sustainable-material-solutions/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/amsilk-zieht-vom-izb-in-groessere-raeumlichkeiten-um-und-plant-den-ausbau-der-produktion-von-nachhaltigen-materialloesungen/" />
		<lastmod>2026-08-12T13:37:08+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/amsilk-office-opneing.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/amsilk-relocates-from-izb-to-larger-premises-with-plans-to-scale-up-its-production-of-sustainable-material-solutions/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/amsilk-zieht-vom-izb-in-groessere-raeumlichkeiten-um-und-plant-den-ausbau-der-produktion-von-nachhaltigen-materialloesungen/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/amsilk-relocates-from-izb-to-larger-premises-with-plans-to-scale-up-its-production-of-sustainable-material-solutions/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/amsilk-zieht-vom-izb-in-groessere-raeumlichkeiten-um-und-plant-den-ausbau-der-produktion-von-nachhaltigen-materialloesungen/" />
		<lastmod>2026-08-12T13:42:43+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/amsilk-office-opneing.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/wir-moechten-das-therapeutische-potenzial-von-aat-fuer-patienten-mit-entzuendlichen-lungenerkrankungen-erschliessen/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/wir-moechten-das-therapeutische-potenzial-von-aat-fuer-patienten-mit-entzuendlichen-lungenerkrankungen-erschliessen/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/we-want-to-unlock-the-therapeutic-potential-of-aat-for-patients-with-inflammatory-lung-diseases/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/wir-moechten-das-therapeutische-potenzial-von-aat-fuer-patienten-mit-entzuendlichen-lungenerkrankungen-erschliessen/" />
		<lastmod>2026-08-12T14:04:24+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/iStock_mi-viri_1360866086_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/we-want-to-unlock-the-therapeutic-potential-of-aat-for-patients-with-inflammatory-lung-diseases/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/wir-moechten-das-therapeutische-potenzial-von-aat-fuer-patienten-mit-entzuendlichen-lungenerkrankungen-erschliessen/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/we-want-to-unlock-the-therapeutic-potential-of-aat-for-patients-with-inflammatory-lung-diseases/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/wir-moechten-das-therapeutische-potenzial-von-aat-fuer-patienten-mit-entzuendlichen-lungenerkrankungen-erschliessen/" />
		<lastmod>2026-08-12T14:04:46+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/iStock_mi-viri_1360866086_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/izb-biotech-news/veredelte-molekuele-die-die-welt-veraendern/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/veredelte-molekuele-die-die-welt-veraendern/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/modified-molecules-that-are-changing-the-world/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/veredelte-molekuele-die-die-welt-veraendern/" />
		<lastmod>2026-08-12T14:18:08+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/heiko-adamski.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/modified-molecules-that-are-changing-the-world/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/veredelte-molekuele-die-die-welt-veraendern/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/modified-molecules-that-are-changing-the-world/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/veredelte-molekuele-die-die-welt-veraendern/" />
		<lastmod>2026-08-12T14:18:31+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/heiko-adamski.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/twogee-biotech-raises-e2-16m-seed-round-for-enzyme-platform/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/twogee-biotech-erhaelt-216-mio-e-seed-finanzierung-fuer-enzymplattform/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/twogee-biotech-raises-e2-16m-seed-round-for-enzyme-platform/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/twogee-biotech-erhaelt-216-mio-e-seed-finanzierung-fuer-enzymplattform/" />
		<lastmod>2026-09-30T11:54:16+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Twogee_team_600x383.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.izb-online.de/en/izb-biotech-news/t-curx-strengthens-in-vivo-car-t-platform-with-pantherna-acquisition-and-achieves-phase-1-approval-for-tcx-001/</loc>
		<xhtml:link rel="alternate" hreflang="de" href="https://www.izb-online.de/izb-biotech-news/t-curx-staerkt-in-vivo-car-t-plattform-durch-uebernahme-von-pantherna-therapeutics-und-erhaelt-phase-1-zulassung-fuer-tcx-001/" />
		<xhtml:link rel="alternate" hreflang="en" href="https://www.izb-online.de/en/izb-biotech-news/t-curx-strengthens-in-vivo-car-t-platform-with-pantherna-acquisition-and-achieves-phase-1-approval-for-tcx-001/" />
		<xhtml:link rel="alternate" hreflang="x-default" href="https://www.izb-online.de/izb-biotech-news/t-curx-staerkt-in-vivo-car-t-plattform-durch-uebernahme-von-pantherna-therapeutics-und-erhaelt-phase-1-zulassung-fuer-tcx-001/" />
		<lastmod>2026-09-30T11:54:16+00:00</lastmod>
		<image:image>
			<image:loc>https://www.izb-online.de/wp-content/uploads/2026/07/Nemes-Laszlo_iStock-2175600990_2000x1098.jpg</image:loc>
		</image:image>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->